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ABSTRACT

B lymphocytes constitute an important arm of the humoral immune system and
protect us by generating antibodies against the foreign antigens we encounter every day.
Mammals use different strategies, to develop and maintain the B cell arm of humoral
immunity. In mice and humans, B cells develop in the bone marrow (BM), where the
primary antibody repertoire is generated. The peripheral B cell compartment in the adults
of these species is maintained by the continuous production of new B cells in the BM. In
other species such as, rabbits, however, B cells develop differently. B cells that develop
in the BM early in ontogeny, migrate to GALT, where in the presence of commensal
bacteria, they undergo proliferative expansion and somatically diversify the
immunoglobulin (Ig) genes. The B cells with a diversified repertoire then enter the
circulation and serve as the pre-immune antibody repertoire. The mechanism(s) that
regulate B cell expansion and diversification in GALT is not known. Further, unlike in
mice, B lymphopoiesis in rabbits is not continuous. After about 3-4 months of age, B
lymphopoiesis arrests, and it is unclear how the peripheral B cell compartment is
maintained when there is no influx of newly-made B cells from the BM.
For my dissertation, I investigated how B cells develop in the GALT of rabbits,
and how they are maintained in adults after the arrest of lymphopoiesis. To identify
cellular signals that promote B cell expansion in GALT, I injected newborn rabbits with
recombinant adenoviruses (rAd) that express soluble decoy receptors. Using this
xii

approach, I identified several cell-cell and cell-cytokine interactions that are required for
B cell development in GALT. I demonstrated that B cells in GALT expand in a CD40CD40L, CD21-CD21L dependent, and B7-CD28 independent manner. By neutralizing a
cytokine, B cell activating factor (BAFF), I demonstrated that BAFF is required for the
differentiation of BM-derived immature B cells (also known as transitional B cells) into
follicular and mature B cells in GALT and peripheral tissues, respectively. Further, I
demonstrated that BAFF provides a survival signal to follicular B cells in GALT.
Using several cross-reactive antibodies, I identified subpopulations of transitional
and mature B cells in young and adult rabbits. Transitional B cells, are the precursors to
mature B cells, and are constantly replenished by the BM in mice and other species. As
described in mice, I identified two populations of transitional B cells: T1 and T2 B cells
in rabbits. Surprisingly, I found that these transitional B cells were present in GALT and
peripheral tissues of adult rabbits, even in the absence of B lymphopoiesis. Unlike murine
T1 B cells that are not proliferating in vivo, and have undiversified Ig genes, T1 B cells in
rabbit were proliferating and were somatically diversified. The presence of transitional B
cells in adults, long after the arrest of lymphopoiesis suggests that they are somehow
maintained since their development early in ontogeny. Further, the presence of a
diversified repertoire indicates that they have gone through a germinal center-like
reaction and are not recent emigrants from the BM. I designate the somatically diversified
transitional B cells in adults as T1d B cells and propose that they are maintained in
GALT by self-renewal. I suggest that self-renewing T1d B cells continuously

xiii

differentiate into mature B cells, and thus maintain peripheral B cell homeostasis in
adults, after the arrest of lymphopoiesis.
While investigating the role of BAFF during B cell development, I was surprised
to find that most primary B cells in rabbit did not bind to recombinant soluble BAFF
(rBAFF), even though they expressed BAFF receptor 3. I was surprised because in other
species, essentially all B cells bind to rBAFF. I demonstrated that primary rabbit B cells
do not bind to rBAFF, because the BAFF-binding receptors (BBRs) on B cells are
occupied by endogenous soluble BAFF. I propose that the chronic occupancy of BBRs on
primary B cells with endogenous BAFF, provides B cells with a tonic/survival signal, and
consequently allows them to remain long-lived.
Taken together, my work provides insights into how B cells develop, and are
maintained in adult rabbits. My work suggests that B cells in GALT develop in a T cell
independent and BAFF and complement dependent manner. In adults, the peripheral B
cell compartment is likely maintained by self-renewing T1d B cells and long-lived
mature B cells.
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CHAPTER ONE
LITERATURE REVIEW
Introduction
B lymphocytes constitute an important arm of the humoral immune system and
protect us by generating antibodies against the foreign agents we encounter every day.
Most of our knowledge about the biology of B lymphocytes is derived from studies using
animal models. Historically, rabbits were used during the early days of immunology by
several investigators to delineate some of the immunological concepts we know today,
such as, allotypes (Oudin, 1956a, b) and allelic exclusion (Pernis et al., 1965, Cebra et al.,
1966). In fact, some of the early studies to elucidate the structure of immunoglobulin (Ig)
were performed using rabbits (Fleischman et al., 1963). Today, with the availability of
several antibody reagents, transgenic and gene knock-out models, the mouse has become
a popular choice for research in B cell immunology. Consequently, B cell development in
mice is relatively well understood when compared to other species, including humans.
Since the early 70s, the focus of B cell development was to understand how the
immunoglobulin genes were rearranged to generate a functional antibody molecule and to
delineate the stages through which hematopoietic stem cells (HSCs) in the bone marrow
(BM) progress to become a B cell (Welner et al., 2008). We now understand that HSCs
1
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progress broadly through a proB and preB cell stage, during which the V, D and J genes
rearrange before giving rise to an immature B cell that exits the BM and enters the
periphery. Once in the periphery, BM-derived immature B cells, designated transitional B
cells go through a series of developmental stages before becoming mature B cells
(Carsetti et al., 1995, Loder et al., 1999). Several questions; however, remain about the
fate of these transitional B cells once they enter the circulation. Only a fraction of the
BM-derived transitional B cells enter the mature B cell repertoire (Allman et al., 1993,
Melchers et al., 1995) and the pathways they use to develop into different mature B cell
subsets are not completely understood (Thomas et al., 2006). Interest in elucidating this
peripheral phase of B cell development was further prompted following the identification
of a cytokine, B cell activating factor (BAFF) (Schneider et al., 1999) and its receptors
(Gross et al., 2000, Thompson et al., 2001). Studies using BAFF and BAFF-receptor
knock-out mice revealed that BAFF was required for the peripheral phase of B cell
development from the transitional stage onwards (Schiemann et al., 2001, Thompson et
al., 2001). Most of these and other studies to understand the peripheral phase of B cell
development are performed in mice and it is unclear how many of these findings relate to
those in other species. In humans, although many aspects of B cell development in the
BM are known and appear similar to mice, very little is known about the peripheral
stages of B cell development (Carsetti et al., 2004). As stated by scientists whom I would
like to call the founding fathers of the field of comparative immunology, Robert Good
and his protégé Max Cooper, the immune system of several species needs to be
investigated to obtain a holistic understanding of the immune system (Flajnik, 2002).
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In this chapter, I will review the current state of knowledge of B cell development
in rabbits and compare that with what is known in other species. I will also raise some
fundamental questions to be addressed, not only in rabbits, but that would also be
applicable towards understanding B cell development in other species as well. In the
latter part of this chapter, I will review the stages of peripheral B cell development, and
the biology of transitional and mature B cell subsets as described in mouse and man.
Development of the primary antibody repertoire
Historically, perhaps one of the most fundamental and debated topics in
immunology was the development of a primary antibody repertoire. How could our
immune system generate antibodies that have an unlimited number of specificities?
Susuma Tonegawa, first solved this problem and showed that in mice, a large amount of
the primary antibody repertoire is generated by the random joining of multiple V, D and J
gene segments during B cell development in the BM (Hozumi and Tonegawa, 1976,
Tonegawa, 1988). After years of debate, this explanation seemed so complete that an
additional or alternate strategy for generation of diversity was not envisioned. Further
support for the idea that the antibody repertoire was generated by random joining came
from studies in humans showing that the human Ig loci are structured and somatically
rearranged in a manner identical to that in mouse (Alt et al., 1987). However, it soon
became clear that “random joining” was not the only mechanism to generate antibody
diversity. While investigating the mechanism for generating the primary antibody
repertoire in other species, several investigators discovered that the random joining of Ig

4

genes contributed relatively little to the primary repertoire, and that they used different
mechanisms: Gene conversion - a process by which portions of rearranged V genes are
replaced by sequences donated from a multitude of upstream pseudo-Vgenes. Also, it
was shown that somatic hypermutation (SHM), introduction of point mutations in
rearranged Ig genes, contributed to the generation of antibody diversity.
In rabbits, the germline contains multiple VH gene segments; however, only one
of them, VH1 is utilized in most B lymphocytes (Knight and Becker, 1990). Similarly,
only two DH gene segments (D2a and D2b) and one JH gene segment (JH4) is
preferentially utilized and expressed (Friedman et al., 1994). While the significance of
such selective utilization of germline Ig genes is not known, it is clear that the B cells
exiting the BM and bearing these rearranged VDJ genes will have only a limited
specificity/repertoire. After birth, this repertoire is greatly expanded in the periphery
through gene conversion and somatic hypermutation (Knight and Barrington, 1998). By
6-8 weeks of age, essentially all peripheral B cells have a diversified repertoire (Crane et
al., 1996), and consequently, the rabbit is considered fully immunocompetent.
Similar to rabbits, chicken B cells also utilize only one V H and one VL gene
segment in their V(D)J gene rearrangements (Reynaud et al., 1985, Reynaud et al., 1987)
and the primary antibody repertoire is generated by the process of somatic gene
conversion (Thompson and Neiman, 1987, Reynaud et al., 1989). However, unlike
rabbits, the antibody repertoire is generated during embryogenesis, and consequently,
chicks are born (hatched) with a full complement of diversified B cells (Reynaud et al.,
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1994). Studies in other species such as, sheep, pigs and cattle, similarly provided
evidence for selective/limited utilization of germline V genes during ontogeny and
expansion of an initial limited repertoire by somatic hypermutation (Reynaud et al., 1991,
Reynaud et al., 1995, Parng et al., 1996, Aitken et al., 1999, Butler et al., 2000).
Although, the random joining of V, D, and J genes in the BM is the predominant
pathway of development of the primary antibody repertoire in mice and humans, there is
some evidence that certain B cell subsets in these species generate their primary antibody
repertoire using alternative strategies. Golby et al. (2002) described a unique subset of B
cells in the human fetal intestine. These B cells had large cytoplasmic processes and were
proliferating, despite the absence of exogenous (bacterial) antigen. They were
CD20+IgM+IgD+ Light chain+ and were located beneath the epithelium and scattered
through the lamina propria. Interestingly, these B cells were present only in fetal
intestine, but not in the postnatal intestinal lamina propria. Analysis of VH gene
sequences from the fetal intestine revealed that some of these B cells had low levels of
SHM. Does this B cell population develop in a pathway analogous to the “GALT”
species? It will be interesting to monitor the fate of these B cells in postnatal life, after the
intestinal tract is colonized by commensal microbiota. Will these B cells migrate to other
sites and/or alter their morphology/phenotype and reside in the intestine to form GC-like
structures?
Several lines of evidence suggest that IgM+ IgD+CD27+ B cells in humans
develop by adopting some of the strategies seen in “GALT” species. Conventionally,
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antibody diversity in humans is first generated by rearrangement of Ig genes during
development in the BM, and later by T cell- and antigen-driven diversification in the
germinal centers (GCs). We acquire the ability to respond to T-dependent antigens, form
GCs and memory B cells soon after birth, but the ability to respond to T-independent
antigens takes a few years to develop (Bauer et al., 2002, Zandvoort and Timens, 2002).
Marginal zone (MZ) B cells are known to mediate an immune response against Tindependent antigens. By performing gene-expression profiling, Weller et al. (2004)
demonstrated that circulating IgM+IgD+CD27+ B cells are MZ B cells and by analyzing
this subset in children below 2 years of age; they found that the VH genes from these B
cells exhibited SHM. By performing spectratype analysis, they found no evidence of
clonal selection; even though the children in the study were vaccinated, and thus exposed
to T-dependent antigens (Weller et al., 2008). The presence of IgM+IgD+CD27+ B cells
with mutated Ig genes in very young children suggests that these B cells are
developmentally programmed to diversify their repertoire during ontogeny. Further, the
presence of this B cell population in patients who are unable to form GCs due to a
mutation in CD40L gene suggests that these B cells can develop outside the boundaries
of a classic T-B cell interaction, which is a hallmark of GC reaction (Weller et al., 2001).
These findings are reminiscent of sheep B cells that diversity their repertoire by SHM and
develop in an antigen and T cell independent manner (Reynaud et al., 1991, Reynaud et
al., 1995). I predict that upon closer observation, human B cell subsets that utilize
somatic gene-conversion will also be discovered. While investigating the mechanism of
isotype switching in an IgH transgenic mice, Gerstein et al. (1990) demonstrated that the
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VDJ transgenes exhibited a somatic gene conversion-like process. More recently,
Shimomura et al. (2008) described a novel subset of B cells in the murine large intestine
that diversified the Ig genes by SHM. These B cells developed in an antigen and T cell
independent manner, and unlike conventional B cells, they were CD21- and CD23(Shimomura et al., 2008).
Thus, the primary antibody repertoire in species can be developed through more
than one strategy, even though one mechanism appears to predominate. Rabbits, are
unusual among mammals in that they utilize both SHM and gene conversion to diversify
their repertoire (Knight and Barrington, 1998). I submit that alternate strategies to
generate and express a primary BCR repertoire are not likely to have been discovered if
studies had focused only on B cells from mouse and human.
Role of GALT in B cell development
When the chicken model of B cell development was first described, it not only
indicated that an alternate strategy for generation of the antibody diversity exists, but also
it introduced gut-associated lymphoid tissues (GALT) as a site where the rearranged
V(D)J genes diversified (Weill and Reynaud, 1987). The bursa of Fabricius, which is part
of GALT, is a primary organ for B cell development in chickens. During ontogeny,
embryonic stem cells colonize the bursa and differentiate into B lymphocytes. These B
cells then undergo a proliferative expansion, form organized follicles, and somatically
diversify the Ig genes. The diversified B cells then leave the bursa and constitute the
peripheral B cell compartment. By 6 months of age, the bursa involutes completely, but
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the B cells generated early in ontogeny are maintained throughout the life of the bird
(Pink, 1986, Pink and Lassila, 1987).
After the initial description of the role of bursa of Fabricius in chicken (Glick,
1956, Mueller et al., 1959), many investigators hunted for the mammalian homologue.
The rabbit appendix received much attention then and was proposed to be the bursalequivalent (Archer et al., 1963, Cooper et al., 1966). This hypothesis was supported by
studies that demonstrated that rabbits appendectomized at birth had significantly reduced
serum Ig levels and reduced antigen-specific Ig responses (Sutherland et al., 1964, Archer
et al., 1964, Cooper et al., 1968). These observations were similar to those in chicken;
bursectomy in the embryo resulted in severe agammaglobulinemia (Glick, 1956, Mueller
et al., 1959, Cooper et al., 1965). Subsequently, the ileal Peyer’s patch (PP) of sheep and
ruminants were also proposed to be a bursal-equivalent (Reynolds and Morris, 1983,
Landsverk, 1984).
Now it is well established that GALT plays an important role in B cell
development in several species. In sheep, clusters of IgM+ B cells are first detected in the
spleen at about day 48 of gestation (the gestation period in sheep is 150 days). Neither the
origin of these B cells nor the stages of development prior to day 48 is known. After
expanding in number in the spleen, the IgM+ B cells seed the ileal PP at about day 68.
Here B cells proliferate vigorously, form organized follicles, and somatically diversify
the Ig genes. About 5% of these diversified B cells leave the PP and enter the circulation,
while the remaining B cells die by apoptosis (Reynolds, 1997). The importance of ileal
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PP in B cell development was demonstrated by its surgical removal; excision of ileal PP
from neonates caused a severe reduction in the number of peripheral B cells (Gerber et
al., 1986). These results again are reminiscent of similar studies of the chicken bursa.
Similar to the bursa, the ileal PP involutes with age (by about 15 months of age), and the
B cells generated early in ontogeny are maintained throughout life (Reynolds, 1997).
In rabbits, B lineage cells are detected in fetal liver (Tunyaplin and Knight, 1995),
and in other sites, such as fetal omentum and spleen (Solvason and Kearney, 1992,
McElroy et al., 1981). Late in fetal life, B cell development switches from liver to the
BM. After birth, BM B cells that have rearranged VDJ genes exit the BM to seed the
peripheral tissues. These B cells migrate to GALT, where they undergo proliferative
expansion, form follicular structures, and somatically diversity the Ig genes. As in other
species described above, the diversified B cells from GALT seed the peripheral tissues
and constitute the primary B cell compartment (Knight and Winstead, 1997). Vajdy et al.
(1998) directly demonstrated the role of GALT in B cell development; surgical excision
of all organized GALT at birth led to the generation of undiversified or poorly diversified
B cells in the periphery. Additionally, the authors found a decline in the frequency of
peripheral B cells after removal of the GALT. These findings not only indicate that
GALT is the site for generation of diversity, but also indicates that GALT functions as a
primary lymphoid organ for the post-natal expansion of B cells. Unlike, chicken bursa
and sheep ileal PP, the rabbit appendix does not involute with age. Instead, the appendix
undergoes a few morphological changes and is thought to function as a secondary
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lymphoid organ in adult rabbits (Weinstein et al., 1994b). Another notable distinction is
that, unlike in chicken and sheep that develop their antibody repertoire during fetal life,
independent of exogenous (bacterial) antigen, B cell development in rabbit requires
antigen (Lanning et al., 2000b). Somatic diversification of the Ig genes begins only after
birth, and after the GALT is colonized by commensal bacteria. Using a germ-free
appendix model, Rhee et al. (2004) demonstrated that both proliferative expansion of B
cells and somatic diversification of VDJ genes in the appendix are dependent on the
presence of commensal bacteria. To investigate the mechanism by which bacteria
promote B cell development in GALT, Severson et al. (2010) tested whether bacterialderived superantigen-like molecules could mediate B cell proliferation in GALT.
Superantigens are molecules that bind outside the conventional antigen binding site and
because almost all B cells in rabbit utilize the same VH gene (VH1) during VDJ gene
rearrangements, a superantigen could readily interact with all B cells, independent of
their BCR specificity (Knight and Winstead, 1997). In support of this idea, Severson et
al. (2010) identified and described a superantigen-like protein, ExsK, found on the
surface of bacterial spores. They demonstrated that surface proteins on bacterial spores
promote B cell development in GALT (Severson et al., 2010).
Much less is known of the mechanism of B cell development in larger animals
such as swine and cattle. B cells in pigs essentially appear to follow a similar
developmental pattern as in rabbits, even though there are some differences in B cell
development at the molecular level (Sun and Butler, 1996, Sun et al., 1998, Butler et al.,
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1996). In pigs, liver is the primary site for B cell development in fetal life until the BM
takes over (Sinkora et al., 2002). Thereafter B cells with rearranged VDJ genes diversify
the Ig genes and studies with germ-free piglets revealed that this process of
diversification after birth requires bacteria (Butler et al., 2000). However, there is no
evidence that swine use GALT as a site for repertoire diversification. The ileal PP are
thought to be a part of the mucosal immune system, rather than a primary lymphoid tissue
during ontogeny (Sinkora et al., 2002). Ig gene diversification in cattle occurs during fetal
development and does not require intestinal microbiota (Lucier et al., 1998). Similar to
sheep, the ileal PP in cattle is a site for generation of the antibody repertoire. In both
these species, although exogenous antigen is not required for development of the
antibody repertoire, it is required for the maintenance of B cells in the follicles (Yasuda et
al., 2002, Yasuda et al., 2006). In summary, B cells in chickens, sheep and cattle
diversify the antibody repertoire during fetal life and independent of exogenous bacterial
antigens. In contrast B cells in rabbits and pigs diversify the antibody repertoire after
birth and require antigen.
Is there a role for GALT during B cell development in mice? During the time that
immunologists were searching for a bursal-equivalent in mammals, the role of murine PP
was also examined. Friedberg and Weissman (1974) hypothesized that if PP functioned
like a bursal-equivalent, then B cells will be exclusively produced in the PP of neonatal
mouse. They monitored the rate of accumulation of B cells in different tissues of
newborn mice and found that the spleen had a greater rate of accumulation of B cells
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compared to PP and lymph nodes. They concluded that the modest levels of proliferation
in the PP could not account for the rise in circulating B cells in neonatal mice and
suggested that the spleen rather than PP might serve as a primary lymphoid organ.
Subsequent studies using [3H]-thymidine labeling and adoptive transfer experiments
revealed that the BM contained B lineage precursors and was the source for B cell
production in postnatal mice (Osmond and Nossal, 1974a, b, Stocker et al., 1974, Owen
et al., 1977, Andrew and Owen, 1978). Around that time, PPs were found to be the source
of precursors for IgA plasma cells (Craig and Cebra, 1971) and studies investigating the
role of IgA in the gut gave rise to the notion that PPs were responsible for local humoral
immunity rather than as sites for B cell production (Cebra et al., 1977).
The contribution of ileal PP in sheep and appendix in rabbit could be directly
examined by their surgical removal (Gerber et al., 1986, Vajdy et al., 1998). However,
because comparable experiments in fetal or neonatal mice cannot be performed due to
technical limitations, I think a role for PPs or other murine GALT during B cell
development cannot be ruled out. Although GALT is not a site for generation of the
antibody repertoire in mice, it may play a role in the development of some B cell subsets
(Shimomura et al., 2008). Similarly, in humans, although BM appears to the predominant
pathway for B cell development, I think some aspects of the GALT pathway may be
conserved. What could be the function of the 200-300 PPs (Cornes, 1965) located along
the human intestinal tract? Is there any role for the human appendix in B cell
development? Rabbit B cells go through human and murine-like developmental stages in
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the BM (see next section) and a chicken and sheep-like development in the GALT. Thus,
rabbits serve as a unique model to investigate the biology of B lymphocytes.
B lymphopoiesis in the BM
B lymphopoiesis, which is defined as the maturation of HSCs to naïve B cells, is
mediated through several stages and occurs predominantly in the BM of mammals. When
considering B cell development in sheep and chicken, much of the emphasis, however, is
on the ileal PP and bursa, respectively. One organ that is conspicuous by its apparent lack
of importance in these species is the BM. Cytological and flow cytometric analysis in
these species revealed that the BM contains few, if any, B lineage cells when compared
to rodents (Reynolds, 1997). HSCs in rodents go through proB and preB cell stages
before giving rise to B cells in the BM. The ordered rearrangement of Ig genes begins in
proB cells where DH to JH gene rearrangements occur. These cells progress to preB cells
following rearrangement of the V to DJ gene and express a preB cell receptor (preBCR).
Signaling through the preBCR is required for the developmental progression into the next
stage, an immature B cell (Kitamura et al., 1992). In sheep, there is no evidence for ProB
and preB cells and essentially nothing is known about the early stages of B cell
development (Reynolds, 1997). In contrast, in rabbits, B-lineage precursors and the
stages of B cell development in the BM are relatively well described. Several groups
reported the presence of preB cells in different tissue during fetal and neonatal life
(Hayward et al., 1978, McElroy et al., 1981, Solvason and Kearney, 1992, Jasper et al.,
2003). These preB cells first appear in fetal BM at day 25 of gestation, and increase in
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number after birth (Hayward et al., 1978, McElroy et al., 1981, Gathings et al., 1981,
Gathings et al., 1982). Jasper et al. (2003) described proB cells in rabbits and followed
the kinetics of appearance of both proB and preB cells after birth. They found that the
percentage of these precursors in the BM peaked at ~ 2-3 weeks of age and reported that
approximately 70% of the B-lineage cells were proB cells and the remaining 30% of the
cells were made up of preB and B cells. Additionally, Jasper et al. (2003) provided
evidence for the expression and formation of a pre-BCR-like complex during B cell
development in the BM. Taken together, these studies suggest that early B cell
development in rabbits proceeds in a fashion similar to that in mice and humans.
B lymphopoiesis in mice and humans continues throughout life. Several lines of
evidence indicate that B lymphopoiesis in rabbits, however, does not continue throughout
life. The earliest evidence came in the form of allotype suppression experiments.
Following administration of anti-allotype antibodies to neonatal rabbits, the targeted
allotype could not be detected in the serum of injected rabbits for up to two years (Mage
and Dray, 1965), presumably due to depletion of the targeted allotype bearing B cells. If
B lymphopoiesis was ongoing, then one would expect to find new B cells, and
consequently re-detect the suppressed allotype in the serum. This was the case when
comparable experiments were performed in mice. In IgH-suppressed mice, new B cells of
the suppressed allotype appeared within 6 weeks of birth (Lalor et al., 1989).
Years later, Crane et al. (1996) examined B lymphopoiesis in rabbits at the
molecular level. The authors hypothesized that if B lymphopoiesis in the BM was

15

ongoing in adult life, then one would expect to find: a) B cells with undiversified VDJ
genes, and b) progenitor B cells undergoing VDJ recombination. Using an RNase
protection assay with a germ-line VH gene (VH1) as a probe, the authors did not find any
evidence for the presence of undiversified VDJ genes in the BM of adult rabbits. By
PCR-amplifying B cell recombination excision circles (BRECs), products of VDJ gene
recombination events, the authors found highly reduced levels of BRECs in the BM of
adult rabbits relative to the levels found in the BM of newborn rabbits. These studies
indicated that B lymphopoiesis does not continue through adulthood in rabbits.
Jasper et al. (2003) followed the kinetics of appearance of B lineage precursors in
the BM and provided evidence at the cellular level for the decline in B lymphopoiesis
with age. As mentioned before, these authors found that the frequency of proB and preB
cells peaked during the first 2-3 weeks of age. However, after this time period, the
frequency of these cells declined gradually. By 16 weeks of age, no proB or preB cells
were detectable in the BM by flow cytometry. The authors also quantified this decline in
B lymphopoiesis at the molecular level. They measured the levels of BRECs in the BM
from different aged rabbits and estimated that by 16 weeks of age, B lymphopoiesis in
rabbits declines by over 99% when compared to newborn rabbits. Taken together, these
data confirmed previous findings by Crane et al and established the kinetics of the decline
in B lymphopoiesis.
B lymphopoiesis in the mouse, although continuous throughout life, also declines
with age. Using Brdu labeling experiments, Labrie et al. (2004) demonstrated that the
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number and production rate of preB cells are reduced ~4 fold in adult mice, when
compared with young animals. Similarly, proB cells and common lymphoid progenitors
(CLPs) have also been reported to decline in frequency with age (Min et al., 2006). What
could be the reason for this decline in B lymphopoiesis? Are there intrinsic defects in the
differentiation capacity of aged precursors, and/or changes in the BM microenvironment
with age? By performing reciprocal adoptive-transfer experiments, Lebrie et al. (2004)
demonstrated that when B cell precursors from both young and adult donor bone marrow
were transferred into young irradiated recipients, B cell subpopulations of identical
magnitude, turnover, and renewal rates were generated. In contrast, when transferred to
aged recipients, B cell precursors from bone marrow of a young mouse gave rise to
relatively fewer B cells. Notably, the pre-B cell compartment that was generated after the
transfer was similar to that found in aged mice, with respect to production and turnover
rates (Labrie et al., 2004). These studies suggest that age-related changes in the BM
environment, rather than defects in the differentiation potential of B lineage precursors
underlie the reduced output of B cells by the BM. While investigating the effects of aging
on early B lineage precursors in the BM, Min et al. (2006) reported that both CLPs and
pro-B cells from aged mice undergo reduced levels of homeostatic proliferation when
compared to their respective counterparts in young animals. Because CLPs from aged
mice exhibited a reduced capacity to give rise to its progenies, the authors suggested that
aging might also influence the differentiation capabilities of B lineage progenitors (Min
et al., 2006).
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To investigate the mechanism(s) by which B lymphopoiesis arrests in rabbits,
Kalis et al. (2007) first determined if the adult BM had any lymphopoietic potential. The
authors transferred BM from adult rabbits into young rabbits and found donor-derived
preB cells and T lineage precursor cells arising in the recipients. Consequently, they
concluded that the adult BM contained a lymphoid progenitor (LP)-like stage that can
give rise to both B and T cells and that B lymphopoiesis arrests at this early LP-like
stage. This conclusion was further supported by the finding that B lymphopoiesis in adult
rabbits could be re-initiated after sub-lethal irradiation. Using anti-MHC II mAb and
recombinant IL7 as reagents, the authors identified and functionally characterized a
population of MHCII -IL7-binding cells that contained putative early lymphoid progenitor
(ELP)-like cells. Preliminary investigations in the Knight lab using antibodies to CD24,
c-kit and CD79a revealed that the MHCII- IL7-binding population contains a CLP-like
population, that resemble murine CLPs both phenotypically and functionally (B.S., V.Y.,
and K.L.K., unpublished observations). It remains to be determined if the frequency and
the differentiation potential of these CLP-like cells are altered between young and adult
rabbits.
In humans, although little is known about age-related changes in B lineage
precursors in the BM, there is considerable information regarding changes in peripheral B
cell subsets with age. Several reports indicate that the total number of CD19 + B cells
decrease with age (Paganelli et al., 1992, Olsson et al., 2000, Breitbart et al., 2002, Chong
et al., 2005, Frasca et al., 2008), presumably due to a decline in B lymphopoiesis. One of
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the consequences of a decline in B cell immunity is a poor response to vaccinations.
Understanding the mechanism(s) by which B lymphopoiesis declines with age will be
useful in identifying therapeutic interventions to restore and maintain B cell immunity in
the elderly.
Peripheral B cell homeostasis
Although B lymphopoiesis in rabbits arrests a few months after birth, rabbits are
able to maintain robust B cell immunity throughout life. In fact, adult rabbits are widely
used to generate high affinity antibody reagents for use in clinical and research
laboratories. How is the B cell compartment maintained in adult rabbits? Perhaps, rabbit
B cells are long-lived and/or self-renewing (Knight and Winstead, 1997). This idea is
supported by the finding that adoptively transferred B cells can be detected for up to 20
months in the recipient rabbit (Adler et al., 1983). This number is considerably higher
when compared to the life-span of murine B cells. Although variable results were
obtained, presumably due of the different approaches used (such as [ 3H] and Brdu
labeling, adoptive transfers and administration of chemical drugs), the life-span of murine
B cells is estimated to range from only a few weeks (~4-6) to months (~4-5) (Fulcher and
Basten, 1997, Hao and Rajewsky, 2001). In mice, B1 B cells are maintained by selfrenewal, unlike conventional B 2 B cells that are continuously replenished (Hao and
Rajewsky, 2001). Although murine-like B1 B cells have not been identified in other
species, it is possible that rabbit B cells functionally resemble B1 B cells and self-renew.
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Even in species that exhibit continuous lymphopoiesis, the mechanisms that
regulate the size and composition of the peripheral B cell compartment are not
completely understood. Even though lymphopoiesis is ongoing and a large number of B
cells are generated in the BM, only a fraction of these newly-formed cells (~3%)
successfully enter the B cell pool (Carsetti et al., 1995). Following experimentallyinduced ablation of B cell development in the BM of adult mice, peripheral B cells still
persist. However, their composition is different; only B1 and MZ B cells remain while
virtually no B2 B cells are found (Hao and Rajewsky, 2001). These observations indicate
that the biology of MZ B cells is different from that of conventional follicular B cells.
Are MZ B cells long-lived? Do they also self-renew like B1 cells? Because B
lymphopoiesis in rabbits arrests so early in life, the humoral immune system must have
developed strategies to maintain B cell immunity throughout life. Investigating these
strategies will provide insights into how B cells are maintained not only in rabbits, but
also, likely, in other species.
Transitional B cells: Intermediates during peripheral stages of B cell maturation
During B cell development, the BM-derived immature B cells, designated
transitional B cells, exit the BM and migrate to the peripheral tissues where they develop
into mature B cells (Carsetti et al., 1995, Loder et al., 1999). These transitional B cells are
identified by several cell surface markers expressed on newly formed B cells in the BM.
In mice, these cells were first identified based on the high expression of heat stable
antigen (HSA), a murine homologue of human CD24; these cells were distinguished from
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mature B cells that were HSAlo (Allman et al., 1992). HSAhi B cells in the periphery
differ from HSAlo B cells in several aspects. First, HSAhi B cells arise before HSAlo B
cells both during ontogeny and during reconstitution of irradiated adults. Second, HSAhi
B cells in the periphery turnover with 4 days, while HSAlo B cells are long-lived. Third,
HSAhi B cells fail to enter cell cycle following BCR crosslinking, while HSAlo B cells
readily enter cell cycle under similar conditions (Allman et al., 1992, Allman et al.,
1993). More recently, the HSAhi cells are referred to as transitional B cells.
Subsequently, Loder et al. (1999) and Allman et al. (2001) demonstrated that
transitional B cells in the periphery could be divided into distinct subsets based on
surface phenotypes. Based on the differential expression of CD21, CD23 and IgD, Loder
et al. (1999) classified the HSAhi transitional B cells into two stages: transitional type 1
(T1) and type 2 (T2). They found T1 B cells in the BM, blood and spleen, while T2 B
cells were found exclusively in the spleen. To investigate the developmental relationship
between T1, T2, and mature B cells, the authors performed adoptive transfers. They
transferred purified T1 B cells into RAG-2 deficient mice, which lack B and T cells, and
detected T2 and mature B cells in the periphery of the recipient mice. Further, following
adoptive transfer of T2 B cells, they detected only mature B cells in the recipients. These
findings indicated that T1 B cells were the precursors of T2 and mature B cells and that
T2 B cells develop into mature B cells. Further, using mice with genetic deletion of
CD45 and Igα, molecules required for BCR signaling, the authors showed that the
development of T2 and mature B cells from T1 cells is dependent on defined signals
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derived from the BCR. Based on these findings, they proposed a linear T1→T2→M
pathway for peripheral B cell maturation (Loder et al., 1999). Using a C1q receptor
homologue, AA4, Allman et al. (2001) identified 3 populations of transitional B cells
based on the surface expression of CD23 and IgM: AA4+CD23-IgMhi (T1),
AA4+CD23+IgMhi (T2), and AA4+CD23-IgMlo (T3). They confirmed that these subsets
are functionally immature, based on their high turnover rates and inability to proliferate
following BCR crosslinking. They also demonstrated that the T1 B cells in their scheme
of classification are the earliest precursors to subsequent stages of B cells during
development.
One major discrepancy between the two schemes of classification described
above is the nature of the late stage transitional B cells. Carstetti and colleagues found
that ~ 20% of the T2 B cells were proliferating in vivo. Consequently, they proposed that
the late stages of B cell maturation are associated with a proliferative burst that may serve
to increase the frequency and number of useful clones entering the mature B cell pool
(Loder et al., 1999, Srivastava et al., 2005). In contrast, none of the three stages of
transitional B cells in the Allman et al. (2001) scheme of classification were proliferating
in vivo. By performing multi-color flow cytometric analysis, they found that T2 B cells in
the Loder et al. scheme did not correspond to their AA4 + B cell subsets. Because HSA is
also expressed at high levels on MZ B cells, they suggested that the Carstetti group’s T2
B cell gate may include some proliferating MZ B cells (Srivastava et al., 2005). Thus,
both these models differ in the characterization of the late stage T2 (and T3) B cells.
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Even though the strategies used to subdivide transitional stages vary, these findings
nevertheless indicate that BM-immature→transitional→mature is likely the major route
of maturation for primary B cells.
Less is known about transitional B cells and the peripheral stages of B cell
development in humans. Carsetti et al.(2004) first attempted to identify transitional B
cells in the blood using a combination of markers that recognized mature naïve, and
memory B cells, and also B lineage precursors in the BM. Accordingly, they used antiCD27 to first eliminate mature memory B cells from their analysis, and identified a single
population of transitional B cells that was CD24hiCD38hi CD10+. Subsequently, other
investigators identified transitional B cells and classified them as T1-like and T2-like
based on the differential expression of CD24 and CD38 (Marie-Cardine et al., 2008) or
IgD and CD38 (Sims et al., 2005). Recently, Suryani et al. (2010), using CD21 as a
marker, identified two transitional B cell subsets (CD21lo and CD21hi) and demonstrated
that the CD21lo subset is the precursor to the CD21hi B cells. Functionally, human
transitional B cells are similar to murine transitional B cells in that they have largely
unmutated Ig genes and do not proliferate upon BCR crosslinking (Sims et al., 2005).
The study of B cell subpopulations in individuals with primary B cell deficiencies
and in patients undergoing hematopoietic stem cell transplants (HSCTs) provided an
opportunity to understand the biology of transitional B cells in humans. Patients with Xlinked agammaglobulinemia (Xid) exhibit a block in B cell development in the BM due
to impaired BCR signaling (Conley et al., 2000). Consequently, they have drastically
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reduced numbers of B cells in the periphery. Suryani et al. (2010) analyzed the residual B
cells in these patients and found that were predominantly CD10+ and CD21lo transitional
B cells. Further, when they analyzed the kinetics of B cell reconstitution in a cohort of
patients undergoing HSCT, they found that the CD21loCD10+ B cells were the first subset
of B cells to appear (Suryani et al., 2010). These findings indicate that these transitional
B cells are the precursors to mature B cells during development. Murine transitional B
cells turnover rapidly and differentiate into mature B cells within 4 days and are
replenished continually from the BM (Allman et al., 1993). In contrast, studies from B
cell depleted and irradiated HSCT patients revealed that human transitional B cells are
relatively long-lived. Transitional B cells normally constitute 2-5% of the B cells in adult
peripheral blood (PB); however, after treatment with anti-CD20 (Rituximab™), nearly all
of the reconstituted B cells in PB are transitional B cells (CD24++CD38++CD10+) and
these cells remain at this frequency for approximately one year (Palanichamy et al.,
2009). Similarly, five months after HSCT, up to 50% of the B cells in PB are transitional
B cells (Marie-Cardine et al., 2008). These data suggest that the turnover rate of
transitional B cells in humans is likely much longer than in mice.
Research from the past decade or so has established transitional B cells as a
crucial link between immature B cells in the BM and mature B cells in the periphery.
While many studies of peripheral B cell development have been performed in mice, and
to a certain extent in humans, essentially no such studies are available in rabbits or other
species that utilize GALT for some aspects of B cell development (Weinstein et al.,

24

1994a, Reynaud et al., 1991, Meyer et al., 1997, Parng et al., 1996, Butler et al., 2000). In
rabbits, and likely in other species, because B lymphopoiesis in primary lymphoid organs
abates early in life (Crane et al., 1996, Jasper et al., 2003), it is unclear how the peripheral
B cell compartment is maintained. Does B cell maturation progress through transitionallike B cell intermediates in these species? Do transitional-like B cells or other
intermediates exist in these species? Because the chicken bursa, sheep ileal PP and rabbit
appendix are important site for B cell development, the B cells emanating from these
organs and trafficking to the peripheral tissues have been proposed to function as
equivalents of transitional B cells in these species (Weill and Reynaud, 2005).
Role of BAFF and APRIL during peripheral B cell development
B cell Activating Factor (BAFF), discovered almost a decade ago, has emerged as
an important regulator of peripheral B cell homeostasis and survival. Schneider et al.
(1999) first identified and characterized human and murine BAFF and demonstrated that
BAFF functioned as a co-stimulatory molecule to induce B cell proliferation in vitro.
Further, using recombinant BAFF (rBAFF) as a tool, the authors discovered that rBAFF
bound predominantly to B cells, suggesting that BAFF-receptor is expressed only on B
cells (Schneider et al., 1999). Subsequent studies by other investigators revealed that
BAFF bound to three receptors: BAFF-R/BR3 (BAFF receptor 3), TACI
(Transmembrane activator and CAML interactor), and BCMA (B cell maturation
antigen) (Gross et al., 2000, Thompson et al., 2000, Thompson et al., 2001). Around this
time, another closely related cytokine APRIL (A Proliferation Inducing Ligand) was also
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identified and was found to bind to two of these receptors: BCMA and TACI (Hahne et
al., 1998, Wu et al., 2000, Yu et al., 2000).
Identification of these novel cytokines and their receptors led several investigators
to develop gene knock-out and transgenic animal models to evaluate their function(s) in
vivo. Mice deficient in BAFF or its receptor BR3 exhibited a block in B cell development
beyond the transitional T1 stage and lacked marginal zone and conventional B2 B cells,
demonstrating that BAFF is required for peripheral B cell maturation and survival
(Thompson et al., 2001, Schiemann et al., 2001, Gross et al., 2001). In contrast,
overexpression of BAFF resulted in an accumulation of B cells and development of an
autoimmune-like phenotype, indicating that optimal levels of BAFF are required for
peripheral B cell development (Mackay et al., 1999). Mice deficient in TACI had
increased numbers of B2 B cells and serum Ig, suggesting that this BAFF/APRIL
receptor has a negative regulatory role in controlling the size of the B cell pool (Yan et
al., 2001). B cell maturation appears normal in both APRIL and BCMA deficient mice;
however, class switching to IgA, and survival of long-lived BM plasma cells were
impaired in April-/- and BCMA-/- mice, respectively (Varfolomeev et al., 2004, Castigli et
al., 2004, O'Connor et al., 2004). These findings demonstrate that BAFF and APRIL
have distinct roles in B cell biology.
In humans, BAFF and its receptors appear to have functions similar to those in
mice. For example, CVID (Common Variable Immunodeficiency) patients that lack
TACI have increased numbers of B cells, but unlike mice, have decreased Ig levels
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(Salzer et al., 2005, Salzer et al., 2009), suggesting that in humans, TACI plays a role in
regulating both the size of the B cell compartment and Ig production . Similar to BR3
deficient mice, CVID patients that lack BR3 also develop severe B cell lymphopenia due
to the arrest of B cell development at the transitional B cell stage (Warnatz et al., 2009).
Even though these phenotypes do not manifest until adulthood, these findings show that
human B cells also rely on BAFF signals for their maturation and survival.
Since the discovery of BAFF in humans and mice, BAFF has been cloned from
chickens, ducks, quails, pigs, and rabbits, indicating that BAFF is evolutionarily
conserved (Schneider et al., 2004, Guan et al., 2007a, b, c, Chen et al., 2009). However,
the receptors for BAFF do not appear to be conserved. In chickens, no evidence for
homologues of TACI, BCMA and APRIL were found, leaving birds with only BAFF and
a single receptor, BR3 to control their B cell compartment. In young chicks, in vivo
neutralization of BAFF with a decoy receptor severely impaired B cell development in
the bursa, demonstrating that BAFF is required for development of bursal B cells
(Kothlow et al., 2007, Reddy et al., 2008).
Unlike mice, the role of BAFF in other mammals such as, rabbits, sheep, cattle
and pigs is not known. Given the crucial role that BAFF plays in murine B cell
homeostasis and survival, it is tempting to speculate that BAFF may play similar
overlapping and/or unique roles in other mammals.
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Mature B cell subsets: Phenotypes, location and functions
Mature B cells in mammals have been variously divided into subsets based on
criteria such as surface phenotype, location and function. In mice, B cells (identified by a
pan B cell marker, B220) are generally classified as B1 and B2 B cells (also known as
conventional B cells). The B2 B cells constitute virtually the entire B cell compartment in
the peripheral lymphoid organs. They are CD23+ HSAlo and express low levels of IgM,
and high levels of IgD (Well et al., 1995). In the spleen, in addition to B2 B cells that
occupy the follicular zone and the red pulp, a small number of B cells (5-10%) reside in
the MZ, which is a major antigen filtering and scavenging area (Martin and Kearney,
2000). Due to their location, MZ B cells are among one of the first cell-types to respond
to blood borne antigens and thus function as a first line of defense. Unlike conventional
B2 B cells that dependent on T cell help in the GCs to differentiate into antibody
secreting cells, MZ B cells can rapidly differentiate into plasmablasts without any T cell
help. These features enable MZ B cells to mount a rapid immune response.
Phenotypically, they are IgMhi, IgDlo, HSAhi and CD23- (Wells et al., 1995). In rodents,
they appear restricted to the spleen and are not circulating. Further, they have largely
unmutated Ig genes (Makowska et al., 1999, Dammers et al., 2000, Allman and Pillai,
2008). In addition to MZ B cells, the spleen also contains a small number of B1 B cells
that phenotypically and functionally resemble MZ B cells (IgMhiIgDloHSAhiCD23-) and
also express CD5 and CD43. These B1 B cells are typically found in the peritoneal and
pleural cavities, where they represent the predominant B cell population. Two functions
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have been attributed to B1 B cells: response to T independent antigens and production of
natural antibodies (Hayakawa and Hardy, 2000, Martin and Kearney, 2001). In the
peritoneal cavity, they contribute to the generation of IgM responses to T-independent
antigens such as phosphorylcholine, an antigen present on many pathogenic bacteria.
They also migrate to the mucosal sites and contribute to the generation of T-independent
IgA responses (Allman and Pillai, 2008). One of the most distinctive features of B1 B
cells is the presence of a restricted BCR repertoire to certain self and bacterial antigens.
The antibodies they secrete are thought to aid in the clearance of common bacterial and
viral pathogens (Ochsenbein et al., 1999, Baumgarth et al., 2000). Thus, similar to MZ B
cells, B1 B cells also function as a first line of defense.
In addition to the unique phenotypic and anatomic localization, B1 and B2 B cells
also differ in their developmental pathway. In adults, B2 B cells which account for ~95%
of the B cells in the spleen and lymph nodes, are continually replenished by de novo
production of B cells in the BM (Hayakawa et al., 1985, Hayakawa et al., 1986, Hao and
Rajewsky, 2001). They can be readily reconstituted in irradiated recipients by transfer of
undifferentiated BM cells, but not by transfer of mature conventional B cells (Wells et
al., 1995). In contrast, B1 B cells develop only early in ontogeny and are maintained
thereafter by self-renewal (Hayakawa et al., 1986, Hao and Rajewsky, 2001). They are
reconstituted by transfers of fetal and neonatal sources of lymphoid precursors, but not by
transfers of adult BM precursors, suggesting that the adult BM does not contain
precursors for B1 B cells (Hayakawa et al., 1985, Solvason et al., 1991, Kantor et al.,
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1992). However, recently, Esplin et al. (2009) identified a progenitor for B1 cells in the
adult BM, suggesting that some B1 B cells can also be derived during adult life. Thus, the
development of B1 and B2 lineage B cells in mice is an ongoing area of investigation.
In addition to B1, B2 and MZ B cells, another subset of mature B cells known as
Bw B cells was recently described in mouse. Thiriot et al. (2007) analyzed several wildderived outbred strains of mice along with the conventional laboratory raised inbred mice
and identified a unique population of B cells, termed Bw B cells, that was conserved
among the genus, Mus. The phenotype they exhibited (CD5-Mac-1+B220hiIgMhiIgDhi
CD43-CD9-) were distinct from both B1 and B2 B cells and these cells were located in
the spleen, peritoneal cavity and PB. By performing adoptive transfers of either fetal liver
cells or T and B cell depleted BM cells from adult mice into Rag2 γc deficient mice; the
authors detected the development of Bw cells, indicating that the precursors for Bw cells
are present in both fetal and adult life. Functionally, Bw cells appeared to possess a
restricted BCR repertoire and secreted natural antibodies like B1 B cells. Lastly, in
addition to describing a novel subset of mature B cells, these authors also introduced
wild-derived mice as another experimental model to study the development and function
of B cell subsets (Thiriot et al., 2007).
In humans, mature B cell subsets are largely defined based on their developmental
stages and functional characteristics such as, mutational status of Ig genes, isotype
switching and ability to secrete antigen-specific antibodies. Accordingly, using a
combination of surface IgD, CD38 and other markers, tonsil B cells were divided into
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five subsets: “naïve” BM-derived B cells (IgD+CD38-) were separated based on the
expression of CD23 into Bm1 (CD23 -) and Bm2 (CD23+) subsets. Germinal center B
cells (IgD-CD38+) were further delineated by CD77 into centrocytes (Bm3) and
centroblasts (Bm4). The IgD-CD38- cells were classified as memory B cells (Pascual et
al., 1994, Liu and Arpin, 1997). With the identification of CD27 as a marker for memory
B cells in humans (Agematsu et al., 2000), a simpler form of classification describing
CD27- B cells as naïve and CD27+ B cells as memory B cells emerged (Weill et al.,
2009). Memory B cells localize in the splenic marginal zone (Liu et al., 1988, Tangye et
al., 1998) and thus CD27 also serves as a marker for MZ B cells in humans. Unlike mice,
these CD27+ marginal zone B cells are re-circulating, have a diversified repertoire and
constitute about 30-40% of the B cells (Dunn-Walters et al., 1995, Tierens et al., 1999,
Weill et al., 2009). A murine like- B1 B cell population has not been clearly identified in
humans, or in other mammals (Thiriot et al., 2007). Thus, most of our knowledge about
B1 B cells is based on studies in mice. It remains to be determined if murine-like Bw B
cells are present in humans and other species.
In rabbits and other fellow “GALT” species, there is no well defined classification
of mature B cell subsets, due to limitations in the availability of antibody reagents. B
cells, for the most part are largely identified by surface IgM or cytoplasmic CD79a that
serve as pan B cell markers. Even though a few antibody reagents have been used to
delineate B cell subsets, it is not known if these subsets are functionally distinct and
parallel the classification scheme used in either mice or humans. Most B cells in rabbits
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are CD5+, unlike in mice, where only subsets of B1 B cells express CD5 (Raman and
Knight, 1992). However, similar to murine B1 B cells that arise early in ontogeny and
express CD43, a subset of IgM+CD43+ B cells have been described in the rabbit appendix
(Fuschiotti et al., 1997). Interestingly, these B cells are only present during the first few
weeks of life, after which they gradually decline with age (Mae Kingzette, personal
communication). These cells may likely represent a B1-like lineage that develop in the
appendix and migrate to other sites such as the peritoneal cavity.
In sheep, a mAb with unknown specificity, called BAQ44A is expressed at high
levels on all B cells in the peripheral tissues. In the ileal PP, only about 5-18% of the B
cells bind to BAQ44A and these B cells express high levels of IgM, while the remaining
B cells are IgMloBAQ44-. Consequently, BAQ44A in sheep is considered a marker for
mature B cells that emigrate from the primary lymphoid organ, ileal PP (Hein et al.,
1989). Gupta et al.(1998) used a different set of markers and described two distinct
subsets of B cells. Using antibodies to the complement receptors, CD21 (CR2) and
CD11b (CR3), they identified CD11b+CD21- and CD11b-CD21+ populations. The
CD11b+ cells were largely non-recirculating, expressed high levels of IgM and localized
predominantly in the splenic marginal zone. On the other hand, the CD11b - B cells were
recirculating and expressed low levels of IgM. Although, it is not known how these
subsets differ functionally, these findings suggest that murine B1 and B2-like and/or MZlike lineage cells may exist in sheep as well.
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Based on the expression of surface CD2, porcine B cells are classified into two
subsets: CD2+ and CD2- (Sinkora et al., 1998). Analysis of the BM and peripheral blood
compartments revealed that CD2 was expressed on B lineage precursors and was either
absent or expressed at low levels on recirculating B cells. This pattern of expression is
analogous to that of murine HSA and suggests that CD2 in swine distinguishes immature
and mature B cells. During fetal and neonatal life, most of the B cells are CD2 + and are
gradually replaced with CD2lo/- B cells, consistent with the appearance of mature B cell
during ontogeny. Interestingly, these changes in the proportions of CD2 + and CD2- B cell
subsets are dependent on the presence of intestinal microbiota. Germ-free piglets have
fewer CD2- B cells in the periphery when compared to age-matched conventional piglets
(Sinkora et al., 1998).
In summary, B cells, when first identified were thought to be a homogenous
population of Ig bearing cells (Wilson and Nossal, 1971). Now, based on flow cytometric
and functional assays, we have discovered several subsets of B cells. Why do we have so
many B cell types? What purpose do they serve in different locations? Our innate
immune system act as first line of defense and plays a crucial role in alerting the adaptive
immune system to danger. B1 B cells, due to their ability to secrete natural IgM and
respond in a T cell independent manner can be considered as part of the innate immune
system. Since they are found in tissues other than the peritoneal cavity, they can be
considered as a mobile arm of innate immunity. MZ B cells, which share some
similarities with B1 B cells, serve as a local defense when pathogens invade the blood
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and reach the spleen. Based on these criteria, the conventional B 2 B cells that enter the
GCs to form memory B cells can be considered as part of the adaptive immune system.
Thus, locations along with distinct competencies of the different B cell subsets serve to
constitute an effective humoral immune system.
Concluding remarks
The advent of recombinant DNA technology in the early 1970s has played a
crucial role in our understanding of the mechanism(s) by which the primary antibody
repertoire is generated. Later, the advent of monoclonal antibodies and technologies to
genetically manipulate the mouse, contributed to our understanding of the development
and function of B cells. The availability of numerous antibody reagents in mice has
helped identify and characterize several phenotypically and functionally distinct B cell
subsets. How these distinct B cell populations are generated and maintained in the
periphery is now an ongoing area of research. Understanding how the peripheral B cell
compartment is maintained may ultimately lead to development of therapeutic strategies
in the elderly where B cell immunity is compromised.
The current working model of B cell development in rabbit was derived largely
from studies aimed at understanding the mechanism and site(s) for generation of the
antibody repertoire. According to the model, B cells develop early in ontogeny and
migrate to GALT where microbial antigens stimulate their proliferation and
diversification (Knight and Winstead, 1997). While the requirement of commensal
bacteria for this early phase of development has been directly demonstrated using a germ-
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free appendix model (Rhee et al., 2004), the mechanism(s) that regulate B cell expansion
and diversification in GALT, and maintenance of peripheral B cells in adults is not
known. For my dissertation, I focused on determining the cellular signals that are
required to promote the proliferative expansion of B cells in GALT, and also the role of
BAFF during peripheral B cell development.

CHAPTER TWO
MATERIALS AND METHODS
Rabbits
Rabbits were from the colony maintained by K. L. Knight at Loyola University
Chicago. Adult rabbits used in this study ranged from 4 months to 2 years of age. All
studies were reviewed and approved by the Institutional Animal Care and Use Committee
of Loyola University Chicago, Maywood, IL.
Thymectomy and anti-CD4 mAb treatment
For depletion of T cells, newborn rabbits were thymectomized by Dr. P.
Sethupathi on day 1 after birth. On days 2 and 5 after birth, the thymectomized rabbits
were injected s.c. with anti-CD4 mAb [5 mg/kg body weight (wt)] (clone Ken4) and
sacrificed on day 8 after birth. The anti-CD4 mAb was purified by passed Ken4-secreting
hybridoma supernatant over a protein G sepharose column.
Cyclosporine A
For depletion of T cells, newborn rabbits were injected (s.c.) daily with
cyclosporine A (CsA) (LC Laboratories, Woburn, MA) at the following doses: 0.4mg/kg
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body wt on day 1 after birth, followed by 15mg/kg body wt from days 2 to 5. Rabbits
were sacrificed on day 6 after birth.
Cobra venom Factor
For depletion of C3 in newborn rabbits, two i.p. injections of Cobra venom factor
(CVF) (Calbiochem, San Diego, CA) (0.5mg/kg body wt) were given at 24 and 48 h after
birth. Rabbits were sacrificed on day 6 or 7 after birth.
Recombinant adenovirus
Adenoviral (Ad) constructs expressing TACI-Ig (extracellular portion of human
TACI fused to human Fcγ) and mouse Fcγ (as control) were kindly provided by Dr. Tong
Zhou (University of Alabama at Birmingham, Birmingham, AL) (Liu et al., 2004).
Rabbit CTLA4-Ig in pCDNA3 vector was kindly provided by Dr. David Dichek,
University of Washington School of Medicine, Seattle, WA. The first two cysteine
residues in the rabbit Fcγ portion (CH2 and CH3) of CTLA4-Ig were mutated into serines
by the Dichek laboratory. I PCR amplified the Ig portion from this construct using
primers: OS-Fcgamma-BAM 5’-atggatccccctcgacatccag-3’, OAMycFc-H3-1 5’tcttctgagatgagtttttgttctttacccggaga-3’ and OAMyc-Fc-H3-2 5’ataaagctttcacagatcctcttctgagatgag-3’ in order to introduce a myc tag after the Ig . The
PCR amplified Ig-myc was then cloned in frame with CTLA4 in pGEM-T vector
(Promega, Madison, WI) and then subcloned into CMV-shuttle vector (Qbiogene,
Carlsbad, CA) following digestion with XhoI and HindIII restriction enzymes. For
constructing CD40-Ig, the extracellular portion of human CD40 was PCR-amplified from
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Raji cDNA (using OS HuCD40XhoI 5’-actcgagaccatggttcgtctgcctctgcag-3’ and AS
HuCD40BamH1 5’-tggatc cccgatcctggggaccacagacaac3’) and cloned into CMV-shuttle
vector, in frame with rabbit Ig-myc. Similarly, the extracellular portion of rabbit CD21
(CR2) was PCR-amplified from appendix cDNA (using OSrCD21Xho 5’actcgaggccgccaccatgggcgccgcg-3’ASrCD21Bam 5’- tggatcccccttcattgcaagaaatgtt-3’) and
cloned into the CMV-shuttle vector in frame with rabbit Fc . Following homologous
recombination and integration of CTLA4-Ig, CD40-Ig or CD21-Ig into the adenoviral
genome, I screened and selected recombinant clones as described by the manufacturer
(Qbiogene, Carlsbad, CA). Adenoviral constructs expressing CTLA4-Ig, CD40-Ig, and
CD21-Ig

µg DNA), were transfected into QBI-293A cells (Qbiogene, Carlsbad, CA)

using Lipofectamine™ reagent (Invitrogen, Carlsbad, CA). Viral particles were isolated
after multiple freeze-thaw cycles and purified using cesium chloride gradients. Virus was
titered using the 50% TCID method (Qbiogene, Carlsbad, CA) and stored at -80oC.
Recombinant viral particles (1010 in 0.3ml PBS) were injected i.p. into rabbit pups within
48 hours of birth and the rabbits were sacrificed 7-10 days later.
Immunization and ELISA
To determine the efficacy of CTLA4-Ig in vivo, rabbits neonatally injected with
Ad-CTLA4-Ig were re-injected with AdCTLA4-Ig at 2 and 5 weeks of age and 3 days
after the 2 week injection, they received 0.5mg Bovine Gamma Globulin (BGG) in
Complete Freunds Adjuvant (s.c.). After the 5 week injection of AdCTLA4-Ig, they
received a secondary immunization of 0.5mg BGG in Incomplete Freunds Adjuvant.
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Serum was harvested on day 7 after the primary and day 10 after the secondary
immunization and anti-BGG IgM and IgG levels were determined by ELISA using antirabbit IgM (clone 367) or anti-rabbit IgG (clone 359; BD Biosciences, San Jose, CA)
coated microtiter plates. The ELISA was developed with goat anti-rabbit H&L chainHRP (Jackson ImmunoResearch, Westgrove, PA) plus ABTS (Sigma Aldrich, St. Louis,
MO) as substrate. The relative levels of serum IgM and IgG in AdCTLA4-Ig-treated and
control PBS-treated rabbits were determined from a linear portion of the dilution curves.
Flow cytometry and immunohistochemistry
Cross-reactive and rabbit-specific antibodies used are shown in tables 1 and 2,
respectively. Indirect reagents that were used are as follows: Dylight 649, 488, or FITC
conjugated goat Fab anti-mouse IgG, and streptavidin FITC, DTAF, PE or APC (Jackson
ImmunoResearch, Westgrove, PA). Rabbit rBAFF, human TACI-Ig, CD40-Ig, and
CTLA4-Ig were biotinylated (1mg) using NHS-LC biotin (Pierce Biochemicals,
Rockford, IL). Biotinylated CTLA4-Ig was used as a reagent to detect surface CD80 and
CD86. Biotinylated PNA was purchased from Sigma, St. Louis, MO. For analysis of
transitional B cells, multicolor flow cytometry (3, 4 or 5 color) was performed by gating
on CD24hi cells that were either CD21lo/CD21+ or IgMlo/IgM+. As a negative control,
cells were stained with isotype control antibodies. All flow cytometry data were acquired
with FACSCanto or FACSCantoII or FACSAria (BD Biosciences, San Jose, CA), gated
on live lymphocyte-sized cells on the basis of forward and side scatter, and analyzed
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using FlowJo software (Tree star, Ashland, OR). All FACs plots using fluorescent
reagents are depicted on a logarithmic scale except where indicated.
For flow cytometric analysis of commensal bacteria, luminal contents were
flushed from rabbit appendix with 1XPBS, 5% fetal calf serum (FACs buffer), and debris
was removed by centrifugation (300 X g) for 1 min. Bacteria were pelleted by
centrifugation (2800 X g) for 15 min and resuspended in buffer. 25-50µl bacteria
(representing a pellet of ~1-2 mm3) were stained in Eppendorf tubes with the appropriate
Abs and analyzed as described above.
For immunohistochemistry, acetone-fixed cryosections (7-8µm) were blocked
with goat serum (5-10%) and then stained with primary Abs (Tables 1&2) and indirect
reagents: Cy2- or Cy3-conjugated streptavidin and Cy2- or Dylight 549-conjugated goat
(Fab) anti-mouse IgG (Jackson ImmunoResearch,Westgrove, PA). Slides were viewed
under a Leica DM IRB microscope (Leica Microsystems, Brannockburn, IL) and images
captured using the MagnaFire 2.1C digital camera system (Optronics, Goleta, CA). The
frozen germ-free (GF) appendix tissues and GALTless spleen tissues used for
immunohistochemistry were obtained from rabbits previously described (Vajdy et al.,
1998, Rhee et al., 2004, Severson et al., 2010).
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Table 1: Cross-reactive antibodies
Antibody Specificity

Clone

Vendor

CD10

Human

CB-CALLA eBiosciences, Inc., San Diego, CA

CD20a

Human

B9E9

Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA
Immunotech, Marseille Cedax, France

CD21

Human

BL13

Immunotech, Marseille Cedax, France

CD23 a

Human

9P25

Immunotech, Marseille Cedax, France

CD24

Mouse

M1/169

eBiosciences, Inc., San Diego, CA
BD Biosciences, San Jose, CA

CD27 a

Human

LT27

AbD Serotec, Oxford, UK

CD38

Human

IB6

Kindly provided by Dr. Malavasi,
University of Turin, Italy

CD62L

Human

LAM-1

Kindly provided by Dr. Tedder,
Duke University, Durham, NC

CD79a a

Human

HM47

BD Biosciences, San Jose, CA

CD90

Human

5E10

BD Biosciences, San Jose, CA

Ki-67 a

Human

B56

BD Biosciences, San Jose, CA

BCL6 a

Human

BL6.02

Thermo Fisher Scientific, Fremont, CA

(PG-B6p)
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Antibody

a

Specificity

Clone

Caspase3

Human/Mouse C92-605 BD Biosciences, San Jose, CA

BR3

Human

pAb b

R&D Systems, Inc., Minneapolis, MN

BAFF a

Human

pAb b

R&D Systems, Inc., Minneapolis, MN

Also used for immunohistology

b

Vendor

Polyclonal antibody raised in Goat
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Table 2: Rabbit specific antibodies
Antibody

Clone

Vendor

IgM a

367

BD Biosciences, San Jose, CA

IgA

102

BD Biosciences, San Jose, CA

IgG

359

BD Biosciences, San Jose, CA

L Chain a

pAb b

KLK Stock

CD1b a

LAT-3

Kindly provided by Dr. Steward Sell,
Albany Medical College, Albany, NY

CD3 a

PC3/188A Spring Valley Laboratories Inc., Woodline, MD

CD4 a

Ken4

BD Biosciences, San Jose, CA

CD9 a

MM2

Antigenix America, Huntington Station, NY

CD11b

198

Antigenix America, Huntington Station, NY

CD11c a

3/22

R&D Systems, Inc., Minneapolis, MN

CD14

K4

Antigenix America, Huntington Station, NY

CD25

Kei-α1

BD Biosciences, San Jose, CA

CD43

L11/43

Antigenix America, Huntington Station, NY

CD44

W4/86

Chemicon International, Temecula, CA

MHC II

2C4

BD Biosciences, San Jose, CA

C3 a

pAb b

SouthernBiotech, Birmingham, AL

MФ a

RAM11

Dako, Carpinteria, CA
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Also used for immunohistology

b

Polyclonal antibody raised in Goat
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In situ hybridization
Paraformaldehyde (4%) fixed tissue sections (10-12µm) were hybridized with 1030ng/ml digoxigenin-labeled riboprobes, 70oC, 20 hr, in a humidified chamber as
described by Hanson and Lanning (2008). Hybridized sections were stringently washed
and incubated with HRP-F(ab’)-anti-digoxigenin followed by biotinyl tyramide (DAKO),
and then AP-F(ab’)-anti-biotin (DAKO, Carpinteria, CA). Sections were developed with
BCIP/NBT (Vector Labs, Burlingame, CA) and examined with the Leica DM IRB
microscope as described above. Riboprobe preparation: Approximately 500-800 bp PCR
product from each gene of interest (BAFF, APRIL, AID, and CD40L) was cloned into
the pGEM-T vector (Promega, Madison, WI). Sense and anti-sense in vitro transcription
templates were generated by PCR amplification from each plasmid, using the appropriate
gene-specific forward or reverse primer, as described below, with a plasmid-specific
primer containing either the T7 or SP6 RNA polymerase promoter (T7 Univ: 5’agtgaattgtaatacgactcactataggg-3’ and SP6 Univ: 5’-cgccaagctatttaggtgacactatagaatac-3’).
200ng of purified PCR product was used as a template in in vitro transcription reactions
containing RNA labeling mix with digoxigenin-UTP (Roche, Mannheim, Germany) and
T7 or SP6 RNA polymerase (Fisher Scientific, Pittsburg, PA). Plasmid template was
digested with RNase-free DNase I (Fermentas Inc., Hanover, MD) and the reactions were
stopped by addition of 0.2M EDTA. RNA transcript integrity and concentration were
assessed by electrophoresis on denaturing polyacrylamide gels (8M Urea and 5%
acrylamide) run in TBE buffer. GenBank accession numbers for nucleotide sequences
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used to prepare riboprobes and primers used are as follows: BAFF (ABP01347;
nucleotides 417-873) (OSRbBAFF 5’-cttaaggcaactcccacaccttctct-3’and OAaHuBAFF 5’cctaggagtgtcgtcaaagttacgtg-3’), APRIL (EF494239; nucleotides 1-753) (RbAPRIL KpnI
F 5’- ggtacccgggctcatgcca-3’ and RbAPRIL BamHI R 5’- tccaggcagtttcacaaaccccaggaag3’), AID (AY928183; nucleotides 1-577) (RbAID F 5’-atggacagcctcttgatgaa-3’ and
RbAID R 5’- tcaaartcccaaagttacgaaatgc-3’) and CD40L (nucleotides 1-785)
(OSrbCD40L 5’-atgatcgaaacgtacagccaacct-3’ and ASrbCD40L 5’tcagagtttgagtaagccaaatga-3’).
Quantitative real-time PCR (qPCR)
Total RNA was isolated from 55D1 B cells, FAC-Sorted IgM+ B cells, BM
CD11b+ cells (gated on side scatter high cells), and peripheral blood (PB) CD14 +
monocytes using RNeasy mini kit (Qiagen, Valencia, CA). cDNA was synthesized
(starting with100ng RNA for each sample) using the Superscript III First-Strand
Synthesis kit (Invitrogen, Carlsbad, CA). BAFF and β-actin (endogenous control) was
PCR-amplified with primers: rb BAFF Forward 5’-tgattgcag acagtgacacaccga-3’, rb
BAFF Reverse 5’-aggtacccggtttctttgaccact-3’ and rb β-actin Forward 5’agatgtggatcagcaagcaggagt-3’, rb β-actin Reverse 5’-agccatgccaatctcgtctcgttt-3’,
respectively on an Applied Biosystems 7300 Real time PCR System (Applied
Biosystems, Foster City, CA). The relative level of BAFF mRNA normalized against βactin was analyzed using the 2 -ΔΔCT method (Livak and Schmittgen, 2001).
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Cloning and expression of BAFF and APRIL
Soluble BAFF (sBAFF) (aa134-284) was PCR-amplified from rabbit appendix
cDNA (OS RbsBAFF 5’-aagcttgttgagggtgtggaagag-3’ and AS RbsBAFF 5’ctcgagcaacaacttcagtgcacc-3’) and cloned into pET-24b vector (Novagen, Madison, WI).
Recombinant sBAFF was expressed in Escherichia coli BL21λ DE3 cells (Invitrogen,
Carlsband, CA) and purified from the insoluble fraction using a Ni2+-NTA agarose
column (Qiagen, Valencia, CA). sBAFF was dialyzed against refolding buffer (0.05M
glycine,0.03M NaOH, 0.4M L-arginine, 1mM dithiothreitol, pH 10.0) for 24 hrs at 4oC,
followed by dialysis in PBS at 4oC (all chemicals purchased from Sigma, St Louis, MO).
Full length BAFF (fl BAFF) was PCR-amplified from appendix cDNA (OS FLRbBAFF
5’-ctcgaggccgccaccatggatgactccacg-3’ and AS FLRbBAFF 5’aagcttcaacaacttcagtgcaccgaagaa-3’) and cloned into pEGFP-N1 vector (Clonetech
Laboratories, Palo Alto, CA), such that BAFF was in-frame with EGFP. Chinese hamster
ovary (CHO) cells were transfected with BAFF-GFP fusion construct and cultured in the
presence of 50µM ChloroMethyl Ketone (CMK) (Calbiochem, San Diego, CA) for 3
days to minimize shedding of BAFF. Only GFP positive cells were analyzed by flow
cytometry for binding to biotinylated TACI-Ig. Soluble APRIL (sAPRIL) (aa105-250)
was PCR-amplified from appendix cDNA using primers: OS RbsAPRIL 5’agatctgcactgcccacccagaaa-3’ and ASRbsAPRIL 5’-ctgcagtcacagtttcacaaaccc -3’. The
underlined nucleotides in the reverse primer indicate a stop codon. The sAPRIL PCR
product was cloned into pDISPLAY vector (Invitrogen, Carlsbad, CA) and transfected
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into 293T cells. Transfected cells were cultured in serum-free media and the supernatant
containing sAPRIL was harvested after 4-5 days and used in B cell stimulation assays.
The nucleotide sequence of all constructs was confirmed by nucleotide sequence analysis.
Western blot
55D1 B cells, FAC-sorted IgM+ B cells, and BM CD11b+ cells (106) were lysed in
buffer containing 4% SDS and 3% DTT and electrophoresed on 12% SDS-PAGE gel.
Proteins were transferred to Immobilon-P Transfer Membrane (Millipore, Bedford, MD)
and probed with a cross-reactive goat anti-human BAFF antibody (ref) (Antigenix
America, Huntington Station, NY), followed by biotinylated rabbit Fab anti-goat IgG
(Rockland, Gilbertsville, PA), streptavidin-HRP (Jackson ImmunoResearch, Westgrove,
PA) and SuperSignal® substrate (Pierce, Rockford, IL). To demonstrate equal loading of
lysates, blots were stipped and re-probed with anti β-actin Ab (clone AC-15; Sigma, St.
Louis, MO).
Proliferation and survival assays
For BAFF and APRIL co-stimulatory experiments, 105 splenocytes and appendix
cells (in 100µl) were cultured with anti-Ig (10µg/ml) [goat (F(ab’) anti-rabbit IgG (H+L);
Jackson ImmunoResearch Laboratories] and varying concentrations of soluble BAFF or
supernatant containing soluble APRIL. Proliferation was assessed by 3[H]-thymidine
(1µCi/well) (Amersham Biosciences) incorporation using a liquid scintillation counter
(PerkinElmer, Inc). As a positive control for proliferation, splenocytes and appendix cells
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were cultured with irradiated murine CD40L-transfected CHO cells in a 100:1 ratio,
respectively and pulsed with 3[H]-thymidine.
For survival assays, appendix B cells were depleted of CD4 +T cells using antiCD4 and anti-mouse Ig coated magnetic beads (MACS; Miltenyi Biotech). Enriched B
cells (106/ml) were cultured in either media alone or BAFF (3µg/ml) or heat inactivated
BAFF (95oC for 30 minutes). Live cells in culture were enumerated after 48 and 96 hrs.
To assess BAFF-binding to in vitro activated B cells, mononuclear cells from
peripheral blood, spleen and appendix were cultured in the presence of anti-Ig (10µg/ml)
and CD40L-expressing CHO cells as described above. After 3 days in culture, live B
cells were analyzed by flow cytometry for BAFF-binding.
Apoptosis and cell cycle analysis
FAC-sorted splenic T1 and mature B cells were cultured with anti-Ig (10µg/ml)
[goat (F(ab’) anti-rabbit IgG (H+L); Jackson ImmunoResearch, Westgrove, PA] for 1215 hours, followed by staining with propidium iodide (PI) and FITC-annexin V (BD
Biosciences, San Jose, CA) and analyzed by flow cytometry as described above.
Similarly, FAC-sorted appendix CD23+ and CD23- B cells were cultured with anti-Ig
(10µg/ml) for 6, 15 and 25 hours, followed by staining with PI and annexin V at each
time point to enumerate the frequency of apoptotic cells.
For cell cycle analysis, FAC-sorted splenic T1 and mature B cells (and CD27+
and CD27- B cells) were cultured with anti-Ig (10µg/ml) or with irradiated murine
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CD40L-transfected CHO cells in a 100:1 ratio, respectively. After 24 h, cells were fixed
with cold 70% ethanol, treated with RNase (50µg/ml), stained with PI (50µg/ml) and
analyzed by flow cytometry (FlowJo software).
Ig secretion assay
FAC-sorted CD27+ and CD27- B cells (104) were cultured (in 200µl) with
irradiated murine CD40L-transfected CHO cells in a 100:1 ratio, respectively, and human
IL4 (100ng/ml) (R&D Systems Inc., Minneapolis, MN). The culture supernatants were
harvested after 7-8 days and the total amount of Ig secreted was measured by ELISA
using anti-L Chain antibody.

CHAPTER THREE
RESULTS
CO-STIMULATORY MOLECULES REQUIRED FOR PROLIFERATIVE
EXPANSION OF B CELLS IN GALT
In mammals that use GALT to generate the primary antibody repertoire, B cells
that seed GALT, expand in number, form organized follicles, and somatically diversify
the Ig genes. In rabbits, using a germ-free appendix model, Rhee et al. (2004)
demonstrated that commensal bacteria are required for the proliferative expansion of B
cells and somatic diversification of Ig genes. The mechanism(s) by which commensal
bacteria regulate these processes in GALT is not known. Little is known about the
cellular interactions, cytokines and other factors that are required to sustain B cell
proliferation and survival in GALT.
To understand the early stages of B cell development in rabbit GALT, I
investigated some of the mechanism(s) by which B cells may be induced to proliferate. B
cells can be stimulated both in a T cell dependent and T cell independent manner,
depending on the nature of the antigen. In T cell dependent stimulation, signal 1 is
delivered to B cells when BCR is cross-linked after binding antigen and signal 2 is
delivered following a direct contact with T cells via the CD40/CD40L interactions and
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other T cell derived cytokines. In contrast, T cell independent stimulation of B cells can
occur through the cross-linking of BCR by highly repetitious molecules such as bacterial
cell wall polysaccharides, or by bacterial superantigens that bind the framework region of
the BCR. In addition, B cells can also be stimulated through other receptors like the toll
receptors, mitogen receptors, complement and BAFF receptors in a T cell independent
manner.
I proposed that B cells in GALT are stimulated by bacteria or bacterial products in
a T cell independent manner. Bacteria may regulate the expression of co-stimulatory
molecules, cytokines, and other factors that are required for B cell proliferation and
somatic diversification of Ig genes. I do not think that B cell development in GALT is
initiated by an antigen-specific (immune) response to bacterial antigens. Rather, I
hypothesized that B cells are stimulated in a polyclonal manner. Thus, if B cell
stimulation is not antigen-driven, then one would predict that T cell help would not be
required during the early phase of B cell development in GALT. This is the case in
sheep. Reynaud et al. (1995) thymectomized a lamb at 70 days gestation and achieved a
peripheral T cell depletion up to 90% and found normal levels of somatic diversification
of Ig genes in this animal. Thus, it appears that T cells are not required for the
development of primary antibody repertoire in sheep. Similarly, I hypothesize that T cells
are not required for B cell development in the rabbit GALT.
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Thymectomy and anti-CD4 mAb treatment to deplete T cells
One approach to directly test if T cells are required for B cell development in
GALT is to develop T cell deficient rabbits and determine if B cells proliferate and
somatically diversify the Ig genes. Because thymectomy combined with high dose antiCD4 mAb treatment in both mice and cattle proved useful in depletion of CD4+ T cells
from both circulation and secondary lymphoid organs (Cobbold et al., 1984, Valdez et al.,
2001), I attempted to deplete T cells in neonatal rabbits using a similar strategy. To
evaluate the effect of anti-CD4 mAb treatment from thymectomy alone, I injected antiCD4 mAb into one of the two rabbits that were thymectomized at birth, and sacrificed
them along with a litter-mate control on day 9 after birth. To determine if T cells were
depleted by this treatment, I analyzed the frequency of CD4 + T cells and IgM+ B cells in
the spleen and appendix and found a similar frequency of T cells in the spleen of control
and thymectomized rabbit, and only a slight reduction in the frequency of T cells in the
thymectomy + anti-CD4 mAb treated rabbit (Fig 1A). To functionally evaluate the effect
of thymectomy + anti-CD4 mAb treatment on the residual T cells, I stimulated
splenocytes from control and treated rabbits with a T cell mitogen, ConA, and measured
proliferation by [3H]-thymidine incorporation. I found approximately a 2-fold decrease in
thymidine incorporation in splenocytes from the treated rabbit when compared to
splenocytes from the control rabbit (Fig 1B). This decrease in [3H]-thymidine
incorporation likely reflects the nearly 2 fold reduction in the number of T cells in the
spleen of the thymectomy + anti-CD4 mAb treated rabbit. I conclude that neither
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thymectomy nor thymectomy in combination with anti-CD4 treatment was effective in
eliminating peripheral T cells.
Similar to the spleen, in the appendix, I found a similar frequency of CD4 + T cells
in the control and thymectomized rabbit (data not shown). However, unlike spleen, I
found no decrease in the frequency of CD4+ T cells in the appendix of thymectomized +
anti-CD4 mAb treated rabbit (Fig 1C). To further confirm this observation, I analyzed
appendix sections by immunohistochemistry, and was surprised to find a lack of welldefined T cell areas (TCAs) in the appendix of thymectomized + anti-CD4 mAb treated
rabbit (Fig 1D, upper panel). Upon closer examination (at a higher magnification), I
found CD3+ T cells scattered throughout the appendix, and found some cells near the
follicle associated epithelium (FAE) (Fig 1D, lower panel). Because CD4 on T cells also
serves as an adhesion molecule (Killeen et al., 1993), I think administration of anti-CD4
likely interfered with the homing and/or retention of T cells in the TCAs of the appendix.
To determine if this altered distribution of T cells in the appendix has any effect on B cell
proliferation in GALT, I stained the appendix for Ki-67, a proliferation antigen, and
found normal expression of Ki-67 in the basolateral region of B cell follicles (Fig 1E).
Taken together, although thymectomy + anti-CD4mAb treatment altered
homing/localization of appendix T cells in this experiment, it did not prove effective in
depleting T cells. Further, thymectomy alone was also not effective in depleting T cells.
Therefore, I looked for alternate strategies to address if T cells are required for B cell
development in GALT.
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Figure 1: Analysis of the T cell compartment in thymectomized and thymectomized
+ anti-CD4 mAb treated rabbits. Flow cytometric staining for IgM and CD4 in the
spleen (A) and appendix (C). B) Splenocytes (105) from the control and treated rabbits
were stimulated with ConA (3µg/ml) for 3 days and proliferation was assessed by [ 3H]thymidine incorporation. D) and E) immunofluorescent staining of the appendix for CD3
and Ki-67, respectively. Arrows indicate T cells lining near the FAE and in small
clusters. Magnification = 100X or 50X.
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Administration of CsA to deplete T cells and/or inhibit their activity
Cyclosporine (CsA) is a widely used immunosuppressive agent. Investigations
into its mechanism(s) of action revealed that it inhibits development of T cells in the
thymus and the function of T cells in the periphery. Jenkins et al. (1988) demonstrated
that administration of CsA in mice inhibited the development of mature single positive
(CD4+CD8- and CD4-CD8+) TCR- αβ+ thymocytes. While investigating the biology of
Cottontail rabbit papillomavirus, Hu et al. (2005) administered CsA into adult rabbits and
found a significant reduction in the percentage of CD4+ and CD8+ T cells in the
peripheral blood, presumably due a block in T cell development in the thymus. Lastly,
while investigating the mechanisms regulating human CD40L gene expression, Fuleihan
et al. (1994), found that CD40L expression was inhibited by pretreatment of T cells with
CsA. Consequently, they suggested that patients receiving CsA may be deficient in
CD40L-dependent T cell help (Fuleihan et al., 1994).
Based on these reports, I reasoned that administering CsA into newborn rabbits
may serve as an alternate strategy to deplete T cells and/or inhibit T-B cell interaction.
Therefore, I administered CsA into two newborn rabbits on day 1after birth and
continued injecting them every day until day 5, and sacrificed the pups along with a littermate control on day 6 after birth. By flow cytometry, I found a significant reduction in
the frequency of CD4+ T cells in the peripheral blood (PB) and spleen of CsA treated
rabbits. Surprisingly, I also did not find any IgM+ B cells in these animals (Fig 2A).
Further, unlike spleen and PB, CD4+ cells were present in the appendix of CsA treated
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rabbits (Fig 2A, lower). While I expected to find a decrease in the number of T cells upon
CsA treatment, I did not expect to find an almost complete absence of the B cell
compartment. To confirm the results of the flow cytometry experiment, I analyzed the
spleen and appendix tissues from CsA treated rabbits by immunohistochemistry.
Consistent with the flow cytometric analysis, I found no B cell follicles either in the
spleen or appendix of CsA treated rabbits, but I did find CD4 + TCAs in the appendix (Fig
2B).
In conclusion, while attempting to deplete T cells using CsA, I serendipitously
discovered that daily administration of CsA in neonates also causes depletion of B cells.
Therefore, I sought an alternate strategy to test whether T cell help is required for B cell
development in GALT.
Inhibition of co-stimulatory molecules involved in T-B cell interactions
One approach to test if T cells are required for B cell development in GALT is to
inhibit T-B cell interactions in vivo, by interfering with essential co-stimulatory signals.
As described previously, during a cognate T-B cell interaction, activated T cells provide
the critical CD40L signal required for B cell activation. Thus, if T cell activation is
inhibited, then CD40L will not be upregulated on T cells, resulting in a block in Tdependent B cell activation. T cell activation can be inhibited through the use of a soluble
CTLA4 receptor, since CTLA4 can effectively block CD28 mediated costimulation of T
cells by a competitive inhibition at the B7 binding site (Linsley et al., 1992).
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Figure 2: Analysis of the T and B cell compartments in CsA-treated and control
(PBS) rabbits. A) Flow cytometry of IgM and CD4 stained cells in the peripheral blood,
spleen, and appendix. B) Immunofluorescent staining for IgM and CD4 in the spleen
(magnification=50X) and appendix (magnification = 50X and 100X). Data in B) are
representative of staining obtained from one of the two CsA-treated rabbits.
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To inhibit T cell activation and thereby prevent T cell help, I injected newborn
rabbits with a recombinant adenovirus (rAd) expressing soluble CTLA4 (CTLA4-Ig).
After 7-10 days, I analyzed the appendix by immunohistochemistry for the presence of
follicles with proliferating (Ki-67+) B cells and found that CTLA4-Ig did not inhibit B
cell proliferation (Fig 3A). To confirm that the absence of a phenotype in the CTLA4-Ig
injected rabbits was not due to insufficient or non-functional CTLA4-Ig, I immunized
two rabbits with a T cell dependent antigen (BGG) and found, as expected, a dramatic
reduction in both primary IgM and secondary IgG (anti-BGG) Ab titers (Fig 3B). Further,
unlike in appendix, CTLA4-Ig inhibited B cell proliferation in the spleen, indicating that
CTLA4-Ig is functional in vivo and inhibits an immune response to a T cell dependent
antigen (Fig 3C).
To determine if the Ig genes in peripheral B cells are somatically diversified in
CTLA4-Ig treated rabbits, ideally, I would clone and sequence Ig genes from B cells of
6-8 week-old rabbits, a time period when B cells with a diversified repertoire begin to
appear (Crane et al., 1996). However, because the titer of CTLA4-Ig was highest during
the first 1 week after injection of rAd, and rapidly dropped thereafter, the presence of
somatic diversification at 6 – 8 weeks of age would not help me determine if CTLA4-Ig
had inhibited somatic diversification. Consequently, I looked for the presence of
Activation-induced Deaminase (AID), an enzyme required for somatic hypermutation, as
an indirect measure to assess if B cells will undergo somatic diversification. If AID is
expressed in the follicles at 1 week of age, then it is reasonable to assume that those B

62

63

Figure 3: Analysis of the B cell compartment in CTLA4-Ig-treated and control (Ig)
rabbits. A) Immunohistochemical staining of the appendix with anti-IgM and anti-Ki-67
mAbs. B) Bar graph showing the primary anti-BGG (IgM) (left) and secondary anti-BGG
(IgG) (right) response, compared to the anti-BGG response from an age-matched
littermate controls (=100%) as determined by ELISA. #1 and #2 represent data from two
AdCTLA4-Ig treated rabbits. C) Immunofluorescent staining of the spleen from one of
the immunized rabbits in b) for IgM and Ki-67. D) In situ hybridization to detect AID
transcripts in the appendix from control and CTLA4-Ig-treated rabbits. Data in A) are
representative of three Ig (control) and CD40-Ig treated rabbits. Magnification = 100X.
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cells are undergoing diversification. I tested for AID expression in 1 week-old CTLA4Ig injected rabbits and found AID transcripts in the basolateral region of B cell follicles
(Fig 3D), suggesting that somatic diversification of Ig genes can occur in the absence of
activated T cells.
To determine if CD40-CD40L interaction is required for the proliferative
expansion and somatic diversification of B cells in the appendix, I injected newborn
rabbits with rAd expressing soluble CD40 (CD40-Ig) and found that it inhibited B cell
proliferation in the appendix (Fig 4A). Compared to control rabbits, I found reduced
levels of AID in the basolateral regions (indicated by arrow) of the B cell follicles (Fig
4D). The reduced expression of AID in CD40-Ig-treated rabbits could be due to lack of
proliferating B cells in the basolateral region of the follicles. These data indicate that
CD40-CD40L interaction is required for B cell development in GALT. Because data
from CTLA4-Ig injected animals suggested to me that CD28 mediated activation of T
cells is not required for GALT development, I asked what could be the cellular source of
CD40L. To address this question, I analyzed young rabbit appendix tissue sections (1
week of age) by immunohistochemistry using purified CD40-Ig as a reagent, to detect
CD40L expression pattern. If T cells express CD40L, and are the primary source of
CD40L in the appendix, then I expected to find CD40-Ig staining the TCAs. Instead, I
found that CD40-Ig stained, albeit weakly, the entire appendix tissue, and not only the
TCAs (Fig 4C). Consistent with CD40Ig staining, I noticed a similar localization of
CD40L transcripts by in situ hybridization (Fig 4D). Although originally described on
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activated T cells, CD40L is also expressed on non-lymphoid cells such as epithelial cells,
monocytes, dendritic cells, fibroblasts, smooth muscle cells and endothelial cells
(Schonbeck and Libby, 2001). Therefore, I think the staining pattern obtained with
CD40Ig and CD40L riboprobe could be due to a low level expression of CD40L by a
variety of cell types in the appendix.
From these studies, I conclude that activation of T cells via the B7-CD28 pathway
is not required for the proliferative expansion and somatic diversification of B cells in
GALT, whereas CD40-CD40L interaction is required. Further, based on the distribution
of CD40L in the appendix, I suggest that non-T cells may be a cellular source of CD40L.
Role of complement during B cell development in GALT
The importance of the complement system in inflammation is well appreciated; however,
increasing evidence supports its important role also in regulation of B lymphocytes
(Carroll, 2004, Tew et al., 2001, Rossbacher et al., 2006). The identification and
characterization of complement receptors CD21 (CR2) on B cells and CD35 (CR1) on
follicular dendritic cells (FDCs) greatly expanded our understanding of how complement
acted on B cells (Tew et al., 2001, Fearon and Wong, 1983, Fischer et al., 1998)

66

accessory cells in the B cell follicles, I reasoned that FDCs may capture and present
bacterial antigens to follicular B cells in the form of immune complexes. These
interactions may in turn promote B cell proliferation and expansion in GALT. To address
whether B-FDC cell interactions via surface CD21 and its ligands are required for GALT
development, I injected newborn rabbits with a rAd expressing soluble CD21 (CD21-Ig)
and analyzed the appendix by immunohistochemistry after 7-10 days. Upon CD21-Ig
treatment, I found little to no Ki-67 expression in the appendix (Fig 5A), indicating that
signaling through CD21 is required for B cell development in GALT. As an alternate
approach, I administered cobra venom factor (CVF) into newborn rabbits and depleted
C3 in vivo (Fig 5B). Using a polyclonal anti-C3 antibody in western blot analysis, I found
no C3 and C3d proteins in the sera of CVF-treated rabbits, while I readily detected these
proteins in control rabbits (Fig 5B). Similar to CD21-Ig treatment, I found that B cell
proliferation in the appendix was inhibited following CVF treatment (Fig 5A, right).
From these experiments, I conclude that complement is required for B cell proliferation
in GALT.
How is complement activated in GALT? Do commensal bacteria play a role in
regulating complement expression and localization in GALT? To address this question, I
examined germ-free (GF) appendix and found no C3 deposition, whereas in conventional
appendices, I found C3 readily localized in the B cell follicles (Fig 6A). To determine if
colonization of the intestine by commensal bacteria induced C3 expression in the
follicles, I examined GF appendices into which select bacteria were introduced (Fig 6B).
The Knight lab previously demonstrated that GALT development was induced in GF
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Figure 5: Analysis of B cell proliferation in CD21-Ig-treated, CVF-treated and
control (Ig) rabbits. A) Immunofluorescent staining of the appendix for IgM and Ki-67.
Data are representative of three Ig (control) and treated (CD21-Ig and CVF) rabbits.
Magnification = 100X. B) Western blot of sera from two control PBS-treated (ctrl #1 &
#2) and CVF-treated (CVF #1&#2) rabbits, probed with anti-rabbit C3. The open
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triangles indicate a 2-fold dilution (1, 0.5 and 0.25µl) of the sera across three lanes for
each animal.
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appendices following the introduction of a select group of bacterial species; E.coli did
not promote B cell expansion, and B. Fragilis induced moderate levels of B cell
proliferation, while B. anthracis induced a relatively robust proliferative expansion of B
cells (Lanning et al., 2000a, Rhee et al., 2004, Severson et al., 2010). In these appendices,
I found almost no C3 deposition in the follicles when E.coli was introduced. In contrast,
in the presence of B. Fragilis and B anthracis, I found staining for C3 in the follicles (Fig
6B), indicating that bacterial species that promote GALT development also induce the
expression of complement in GALT. To further characterize the role of complement, I
examined if C3 was deposited on the surface of commensal bacteria. By flow cytometry,
I found that luminal bacteria were coated with C3 and IgA, and the IgA+ bacteria
appeared to have a greater deposition of C3 on the surface compared to IgA - bacteria.
Taken together, I conclude that commensal bacteria regulate the localization/deposition
of complement in GALT.

ROLE OF BAFF AND APRIL DURING B CELL DEVELOPMENT IN GALT
BAFF has been shown to be required for peripheral B cell development in mice,
while it is dispensable during B cell development in the primary lymphoid organ, the BM
(Schiemann et al., 2001). Because the rabbit appendix is a site for B cell expansion, and
considered a primary lymphoid tissue, I examined the role of BAFF and APRIL during
the early phase of B cell development in GALT.
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Figure 6: Analysis of appendices from germ-free and conventional rabbits for C3.
Immunofluorescent staining for IgM and C3 in appendix sections from conventional 4 wk
old rabbit (upper) and 4 wk old rabbit with a germ-free appendix (lower) (A) and from
GF appendices into which E.coli (upper), B.fragilis (middle) and B.anthracis (lower)
were introduced (B). Arrows indicate staining for C3 in the follicles. Magnification =
100X. C) Flow cytometric analysis of IgA- and C3- stained intestinal commensal
bacteria from 6 week old rabbit. Plots are representative of two independent experiments.
Magnification for all figures = 100X
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BAFF and APRIL expression in GALT
To determine if BAFF and APRIL play a role during B cell development in
GALT, I first examined their expression in the appendix, and tested if the expression of
BAFF, like complement is regulated by commensal bacteria. I examined BAFF
expression in GF and conventional (CV) appendices by immunohistochemistry and found
that while BAFF was readily detected in the B cell follicle areas of CV appendices, little
to no BAFF was detected in the GF appendices (Fig 7A upper). However, following
introduction of commensal organisms, B. subtilis and B. fragilis or B. anthracis, BAFF
was detected in the B cell follicle areas (Fig 7A bottom). These data demonstrate that
intestinal microbiota is required for BAFF expression and localization in GALT. By in
situ hybridization, APRIL transcripts were detected near the FAE and villous epithelium
(VE) (Fig 7B left). In contrast, BAFF transcripts were detected around the B cell follicles
(Fig 7B middle), where proliferating B cells reside (Fig 7B right). Because BAFF is
known to be expressed by macrophages and dendritic cells (DCs) (Schneider et al., 1999,
Nardelli et al., 2001), I considered that the BAFF in B cell follicle areas could be derived
from resident macrophages and DCs. However, by immunohistochemistry, macrophages
and DCs were detected predominantly in the domes (Fig 7C), while most of the BAFF
transcripts were detected in the B cell follicles and some in the domes (Fig 7D). These
data suggest that the BAFF in B cell follicles is not produced by DCs and macrophages,
but instead is produced by B cells.
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Figure 7: Immunohistochemistry and in situ hybridization to detect BAFF and
APRIL in GALT. A) Immunofluorescent staining for IgM and BAFF in appendix
sections from conventional (4 wk old), germ-free (4 wk old), and germ-free appendix
rabbits in which the appendix was colonized with B. subtilis and B. fragilis or B.
anthracis (7 wk old). B) In situ hybridization to detect APRIL (left) and BAFF (middle)
transcripts in appendix (4 week-old CV) and immunofluorescent staining for IgM and
Ki-67 (right) in appendix (2 week-old CV). C) Immunofluorescent staining of neonatal
appendix (1 wk of age) for B cells (anti-IgM) and dendritic cells (DCs) (anti-CD11c)
(top panel) and macrophages (MФ) (RAM11) (bottom panel). The dotted line indicates
a representative follicle (F) and dome (D). D) In situ hybridization to detect BAFF
transcripts in a neonatal appendix (1 wk-old CV). VE= Villous epithelium; D= dome;
F=follicle. Magnification is 100X or 50X.
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Expression of BAFF by B cells
To directly test if B cells produce BAFF, I used 55D1 B cells (a rabbit B cell
line), and FAC-sorted IgM+ B cells from appendix, spleen and PB, and performed real
time-PCR and western blot analyses. Since myeloid cells express BAFF (Nardelli et al.,
2001), I included CD11b+ myeloid cells from the BM and CD14+ monocytes from PB as
positive controls. By both assays, I found that 55D1 B cells as well as IgM+ B cells from
appendix, spleen and PB expressed BAFF (Fig 8A and 8B). BAFF, which is a type II
transmembrane protein, is proteolytically cleaved on the cell surface to generate soluble
BAFF (sBAFF) (Schneider et al., 1999). To determine if BAFF expression can be
detected on the surface of B cells, I stained primary B cells and two B cell lines, 55D1
and PBL-1 (Sethupathi et al., 1994, Knight et al., 1988), with biotinylated TACI-Ig.
Some of the B cells bound TACI-Ig (Fig 8C), albeit weakly, indicating that they express
BAFF. As a positive control, CHO cells transfected with full length rabbit BAFF readily
bound TACI-Ig (Fig 8D). Together, these results show that rabbit B cells express BAFF.
Recent reports demonstrated BAFF transcript and protein expression in mouse and
human B cells; however, membrane expression of BAFF was undetectable on most
freshly isolated human peripheral B cells, presumably, due to rapid shedding of BAFF
(Darce et al., 2007, Li et al., 2008). In mice, only B1 B cells displayed low levels of
membrane BAFF (Chu et al., 2007). Thus, in rabbits, I suggest that the BAFF expressing
B cells may represent a B1-like subset.
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Figure 8: BAFF expression in B cells. A) Quantitative-PCR for BAFF transcripts from
55D1 B cells, BM CD11b+ myeloid cells, PB CD14+ monocytes, and IgM+ appendix
(Apx), spleen (Spl), PB B cells. Data are represented as fold changes of BAFF mRNA
relative to BM CD11b+ myeloid cells. Error bars= standard error of the mean derived
from triplicate PCR reactions. B) Western blot of lysates from 55D1 cells, BM CD11b+
myeloid cells and IgM+ Apx, Spl and PB B cells probed with anti-BAFF. C) Flow
cytometric analysis of IgM+ cells from appendix, spleen, PB, and B cell lines, 55D1 and
PBL-1, stained with biotinylated TACI-Ig (open histograms) and human IgG as isotype
control (shaded histograms). D) Flow cytometric analysis of CHO cells transfected with
full length BAFF and stained with biotinylated TACI-Ig (open histogram) or biotinylated
human IgG as isotype control (shaded histogram). Mock = CHO cells transfected with
empty vector. Data are representative of two (qPCR), four (western blot) and three (flow
cytometry) experiments.
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Requirement of BAFF/APRIL for GALT development
To determine if BAFF and/or APRIL are required for B cell expansion in GALT,
I used a soluble decoy receptor approach to neutralize these cytokines in vivo. I injected
newborn rabbits with rAd expressing TACI-Ig, and after 7-10 days analyzed the appendix
by immunohistochemistry for the presence of Ki-67+ proliferating B cells (Fig 9A). I
found little to no Ki-67 expression in the appendix, and the B cell follicles were markedly
reduced in size compared to control rabbits. Consistent with these immunohistochemical
results, by flow cytometry, I found the percentage of IgM+ B cells was greatly reduced in
TACI-Ig treated rabbits, when compared to Ig controls (16.8% vs. 47%) (Fig 9B).
Similar to the appendix, B cells in the spleen and PB were markedly reduced (Fig 9A
lower and 9B). In BM, I did not find any perturbation in the B cell compartment of
TACI-Ig treated rabbits (Fig 9C). The frequency of precursor B cell populations, pro and
preB cells, as well as antigen presenting cells (MHCII +) and other hematopoietic (CD43+)
precursors were similar between rabbits injected with TACI-Ig and control rAd. Taken
together, these experiments indicate that neutralization of BAFF/APRIL by TACI-Ig
blocked B cell development in GALT and peripheral tissues, while leaving the BM B cell
compartment intact.
Stimulation of appendix B cells by BAFF and APRIL
Inhibition of B cell development in GALT by the BAFF/APRIL decoy receptor
suggested to me that appendix B cells may be stimulated to proliferate by these
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Figure 9: Analysis of the B cell compartment in TACI-Ig-treated and control (Ig)
rabbits. A) Immunofluorescent staining for IgM and Ki-67 in the appendix and for IgM
and CD4 in spleen B) Flow cytometry of IgM and CD4 stained cells in appendix, spleen
and PB. C) Flow cytometry of bone marrow stained with antibodies to surface L chain
and cytoplasmic CD79a (left), cytoplasmic IgM (center) and CD43 and MHC II (right).
Data are representative of three control rabbits and five TACI-Ig treated rabbits.
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cytokines. To test if BAFF and APRIL co-stimulate GALT B cells, I cultured appendix
cells with anti-Ig and recombinant soluble BAFF (rBAFF) and APRIL (rAPRIL) and
measured proliferation by [3H]-thymidine incorporation. While splenocytes exhibited a
robust dose-dependent proliferative response to both rBAFF and rAPRIL, appendix B
cells showed only a modest two-fold increase in [3H]-thymidine incorporation (Fig 10A
and 10B). As a positive control for proliferation, appendix B cells readily responded to
CD40L stimulation (Fig 10C). To investigate whether BAFF provides a survival signal to
GALT B cells, I cultured appendix B cells with BAFF and found approximately two to
four-fold more viable B cells in rBAFF-containing cultures as compared to media alone,
or denatured BAFF containing cultures (Fig 10D). I conclude that neither BAFF nor
APRIL provide a strong co-stimulatory (proliferative) signal to appendix B cells.
Appendix B cells also did not proliferate in response to anti-Ig stimulation alone,
indicating that B cells in appendix are functionally different from those in spleen.
Occupancy of BAFF binding receptor(s) on primary B cells
To determine the expression pattern of BAFF-binding receptors(s) (BBRs) on
GALT and peripheral B cells, I stained B cells with biotinylated rBAFF and was
surprised to find that most B cells from appendix and PB did not bind rBAFF (Fig 11A).
This was unexpected because studies with primary human and murine B cells showed
rBAFF binding to almost all B cells (Avery et al., 2003, He et al., 2004, Schneider et al.,
1999, Thompson et al., 2001). I ruled out the possibility that the lack of binding was due
to defective rBAFF reagent by testing it on B cell lines and found that rBAFF bound to
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five of six B cell lines of rabbit, human and mouse origin (Fig 11B). Next, I considered
that the lack of binding of rBAFF to primary B cells could be due to the lack of BR3, a
predominant receptor on murine and human B cells. However, by flow cytometry, I
found B cells from appendix, PB, and spleen expressed BR3 (Fig 12A). To test if the lack
of rBAFF binding was due to occupied receptors, I used an anti-BAFF antibody that
primarily detects surface bound BAFF (Darce et al., 2007) and found that all B cells
reacted with this antibody (Fig 12B), suggesting that the BBRs have endogenous BAFF
already bound and therefore are unavailable to bind rBAFF. However, primary B cells
that were activated in vitro with anti-Ig and CD40L did bind rBAFF (Fig 12C),
suggesting that upon activation, B cells either lose surface bound BAFF and/or synthesize
new BBRs that can bind rBAFF. I conclude that in rabbits, most primary B cells do not
bind rBAFF because the BBRs are already occupied.
Binding of rBAFF to peripheral blood monocytes and splenic marginal zone B cells
As shown in Fig 11A, I observed some cells in PB and spleen that bound rBAFF.
Surprisingly, most of these rBAFF-binding cells in blood were MHCII+ (Fig13A),
CD11b+ and CD14+ (Fig 13B), indicating that BAFF binds PB monocytes. Ritter et al.
(2006) showed that CD44 could be used as a marker to distinguish between murine
myeloid and lymphoid cells, and I first used anti-CD44 mAb to determine if CD44 could
distinguish rabbit myeloid and lymphoid cells. I identified CD44 lo and CD44hi subsets of
MHCII+ cells in PB (Fig 13C upper) and showed that the CD44hi subset consisted of
mostly CD14+ and CD9+ myeloid cells (Fig 13C lower middle and right) and the CD44lo

85

86

Figure 10: In vitro stimulation of GALT B cells with recombinant BAFF and
APRIL. Splenocytes and appendix cells cultured for 72 hrs with anti-Ig (10µg/ml) and
increasing concentrations of A) soluble BAFF (sBAFF) or B) supernatant containing
soluble APRIL (sAPRIL) (5-40%). Proliferation was assessed by 3[H]-thymidine
incorporation. C) Splenocytes and appendix B cells co-cultured with and without CD40Lexpressing CHO cells in a 100:1 ratio, respectively. Proliferation was assessed by 3[H]thymidine incorporation. D) CD4+ depleted appendix B cells were cultured in either
medium alone, or in media supplemented with sBAFF or denatured sBAFF. Live cells in
culture were enumerated after 48 and 96 hours (h). Error bars = standard error of the
mean derived from triplicate wells. Data are representative of three independent
experiments.
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Figure 11: Flow cytometric analysis of rBAFF-binding to B cells. A) Staining of
freshly isolated appendix, PB and spleen cells with anti-L chain and biotinylated rBAFF.
B) Histograms of B cell lines, 55D1, 79E and PBL-1 (rabbit), Raji and BJAB (human)
and A20 cells (mouse) stained with biotinylated rBAFF (open histograms) followed by
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streptavidin PE. Negative control= cells stained with steptavidin PE only (shaded
histograms).
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Figure 12: Flow cytometric detection of BR3 and BAFF on appendix, PB and splenic
B cells. Cells stained with A) anti-IgM and goat anti-BR3 followed by biotinylated rabbit

(Fab) anti-goat Ig and streptavidin PE. B) Gated IgM+ cells stained with goat anti-BAFF
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followed by biotinylated rabbit anti-goat Ig and streptavidin PE. C) Anti-Ig and CD40L
activated B cells stained with anti-IgM and rBAFF.
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Figure 13: BAFF-binding to PB monocytes. Flow cytometric staining of PB
lymphocytes with A) rBAFF and anti-MHCII, B) anti-CD11b, anti-CD14 and rBAFF. C)
Top: Flow cytometric analysis of MHCII+ cells for CD44 expression. CD44hi and CD44lo
subsets indicated by vertical dashed line. Bottom: Analysis of CD44lo cells for L chain
expression (left) and CD44hi cells for CD14 and CD9 expression (middle and right). D)
Flow cytometric staining of CD44 hi and CD44lo subsets of MHC II+ cells with rBAFF.
Shaded histogram= isotype control.
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subset comprised of L chain+ B cells (Fig 13C lower left). By using CD44 as a pan
marker to distinguish rabbit myeloid and lymphoid cells (Fig 13D), I confirmed that
rBAFF binds strongly to CD44hi myeloid cells and only weakly to CD44lo B cells. In the
spleen, most of the BAFF-binding cells were B cells (Fig 11A). Since in vitro activated B
cells bound rBAFF (Fig 12C) and MZ B cells are likely activated and express high levels
of TACI (Kanswal et al., 2008), I tested if the subset of splenic B cells that bound rBAFF
were MZ B cells. Because CD9 is expressed on some MZ B cells in mice (Won and
Kearney, 2002), I used anti-rabbit CD9 mAb to identify MZ B cells in rabbit spleen. By
immunohistochemistry, I found BAFF- binding and CD9 expression around the margins
of B cell follicles (Fig 14A), suggesting that BAFF may be binding to MZ B cells. By
flow cytometry, using anti-CD9 mAb, rBAFF and anti-L chain, I found that a subset of
CD9+ B cells bound rBAFF (Fig 14B). Taken together, I conclude that rBAFF binds PB
monocytes and also to a subset of CD9+ splenic MZ B cells.
Binding of rBAFF to a subset of IgM lo B cells
Although most freshly isolated B cells from adult rabbit PB and appendix did not
bind rBAFF (Fig 11A), in neonates, I found a subset of IgMlo B cells from appendix and
spleen that did bind rBAFF (Fig15A left panel). In the appendix follicles, these rBAFF+
cells were located in the basolateral region (Fig 15B) where Ki-67+ proliferating B cells
reside (Fig 9A), suggesting that these subsets are cycling in vivo. Further, in TACI-Ig
treated rabbits, over 30% of the B cells in appendix (11.6% of 30.2%) were IgM lo and
bound rBAFF, while only about 10% of the B cells in the control rabbits (6.5% of 70.3%)
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Figure 14: BAFF-binding to splenic MZ B cells. A) Immunofluorescent staining of
spleen with rBAFF and anti-CD9 mAb. B) Flow cytometric analysis of splenocytes with
anti-CD9, rBAFF and anti-L chain.
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Figure 15: Identification of an IgMlo BAFF-binding B cell subset (transitional-like
B cell) in neonates. A) Staining of appendix and spleen cells from TACI-Ig treated or
control rabbits with anti-IgM and rBAFF. Arrow identifies IgMlo rBAFF-binding B
cells. B) Immunofluorescent staining of normal appendix with anti-IgM and rBAFF. C)
Staining of PB from a newborn rabbit with anti-IgM and rBAFF. Data in A) are
representative of two rabbits in each group.
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bound rBAFF (Fig 15A). This accumulation of rBAFF+ IgMlo B cells in TACI-Ig treated
rabbits suggests that this subset depends on BAFF for maturation and represents
transitional-like B cells that arise early in development. In support of this idea, I found
that most B cells in the peripheral blood of a newborn rabbit (2 day old), expected to be
immature or transitional-like B cells were IgMlo and many of these bound rBAFF (Fig
15C). In the next section, I further characterized these transitional-like B cells.
IDENTIFICATION OF TRANSITIONAL B CELLS
The presence of a rBAFF-binding IgMlo transitional-like B cell subset in
neonates, and their accumulation in TACI-Ig treated rabbits, suggested to me that B cells
in rabbit go through a transitional-like stage during development. To understand the
biology of these B cells, I further phenotypically and functionally characterized them in
young and adult rabbits.
Identification of transitional B cell subsets
One major difficulty in identifying B cell subpopulations in rabbits is the lack of
antibody reagents. As I mentioned previously, the only B cell markers available are
antibodies to IgM or cytoplasmic CD79a which are pan B cell markers and would not
allow me to easily identify B cell subsets. To overcome this difficulty, I discovered
several crossreactive antibodies and identified B cell subpopulations in adult rabbits,
based on the expression of surface markers used to delineate immature and mature B cells
in mice and humans. Because human CD24 and its murine homologue, HSA, are
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expressed early in B cell development on both BM B cell progenitors and transitional B
cells, but are downregulated on mature B cells (Allman et al., 1992, Carsetti et al., 2004),
I tested if anti-CD24 can be used to identify transitional B cells in rabbits. Using antiCD21 and anti-CD24 mAbs, I identified two subsets of CD24hi B cells in the spleen
(CD21lo and CD21+), which I will henceforth refer to as T1 and T2 B cells, respectively,
and a CD24-CD21+ subset, designated mature (M) B cells (Fig 16A top). T1 B cells were
IgMlo CD62Llo, while both T2 and mature B cells had higher levels of CD21, surface
IgM, and CD62L expression (Fig 16A top). CD23 was expressed at similar levels on both
T1 and T2 B cells (Fig 16A top) and thus did not serve as a useful marker to distinguish
between these B cell subsets. To determine if these transitional B cells share features with
human transitional B cells, which are broadly defined as CD24hiCD38hiCD10+CD20hi
(Cuss et al., 2006), I analyzed the CD24hi cells for these markers and found that the T1 B
cells were CD10loCD38+, while the T2 B cells were CD10hi and CD38hi ( Fig 16A
bottom). Interestingly, CD20 was expressed on the T1 and T2 cells but not on the mature
B cells, and thus served as a unique marker to identify transitional B cells (Fig 16A
bottom). Further, T1 and T2 B cells expressed high levels of CD90 (Fig 16A bottom), a
phenotype shared with rat immature B cells (Dammers et al., 2000). Unlike in spleen, I
observed only a single subset of CD24hi cells in the PB and these had a lower expression
of CD21 compared to mature B cells (Fig 16B left). These cells were IgMloCD62Llo (Fig
16B right), suggesting that PB contains only a T1-like population of transitional B cells. I
observed a similar T1-like CD21loCD24hi subset in GALT [appendix (Apx), sacculus
rotundus (SR), Peyer’s patch (PP) and mesenteric lymph node (MLN)] (Fig 16C). Taken
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Figure 16: Flow cytometric identification of transitional B cell subsets in adult
rabbits. A) Staining of splenic B cells for CD21 and CD24, with IgM, CD62L, CD23,
CD10, CD38, CD20 and CD90 histograms of cells in T1 (red), T2 (green) and mature
(M) (blue) cell gates. B) Staining of PB lymphocytes for CD24 and CD21, with IgM and
CD62L histograms of cells in T1 (red) and M (blue) cell gates. C) Lymphocytes from
appendix (Apx), sacculus rotundus (SR), Peyer’s patches (PP) and mesenteric lymph
nodes (MLN) stained for CD24, CD21 and IgM; analysis of cells in IgM+ gate is shown.
The gray filled histograms in A and B represent staining with an appropriate isotype
control mAb. The plots are representative of staining obtained from at least 3 rabbits.
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Table 3: Frequency of transitional B cells in adult rabbits

a

Tissuea

T1b

T2b

Spleen (11)

7.2 ± 2

13.6 ± 2.3

Blood (6)

2.9 ± 0.9

ND

Appendix (6)

2 ± 0.4

ND

Sacculus rotundus (3)

3.8 ± 0.9

ND

Mesentric lymph node (4)

3.7 ± 0.9

ND

Peyer’s patch (2)

9.8 ± 3.8

ND

The number in parentheses indicates the number of rabbits analyzed

b

Indicates the percent of total B cells and ± represents the standard error of the mean

T1 = CD24hiCD21lo T2 = CD24hiCD21+
ND = Not detectable
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together, these results demonstrate that in adult rabbits, immature B cells can be
phenotypically delineated into two transitional B cell subsets, similar to murine T1 and
T2 B cells. The frequencies of these cells in different tissues are shown in Table 3
Functional analysis of transitional B cells
In vivo, murine transitional B cells require BAFF for maturation into B cells, and
in the absence of BAFF, peripheral B cell development is blocked at the T1 stage
(Schiemann et al., 2001). If the CD24hiCD21lo B cells in rabbit are in fact T1 cells and
require BAFF for maturation, then I predicted that the absence of BAFF would block
peripheral B cell development at the T1 stage. I therefore neutralized BAFF by injecting
newborn rabbits with a soluble decoy receptor (TACI-Ig) and found, as predicted, a
dramatic decrease in splenic T2 and mature B cells, while the T1 B cell population
remained intact (Fig 17A left). Similarly, in the appendix, the mature B cell population
was eliminated by neutralization of BAFF, but the CD24hi transitional B cell population
was not reduced, but instead appeared to accumulate (5.1% vs 9.5%)(Fig 17A right).
These data indicate that CD24hiCD21lo B cells are murine-like T1 cells that require BAFF
for their maturation. Further, the absence of splenic T2 and mature B cell compartments
upon TACI-Ig treatment suggests to me that T1 cells give rise to T2 cells, which in turn
likely develop into mature B cells. These data also indicate that GALT T1 cells are
functionally similar to splenic T1 cells in their requirement for BAFF to differentiate into
mature B cells that occupy the B cell follicles.
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Figure 17: Functional analysis of transitional B cells. Flow cytometric analysis of
appendix and spleen cells stained with A) anti-CD21 and anti-CD24 in TACI-Ig-treated
and control (Ig) rabbits, B) Anti-CD24 and rBAFF, C) upper: anti-CD24 and anti-L
chain; lower: anti-Ki67 (open histograms) of T1 cells from upper diagram. Shaded
histogram = isotype control. Flow cytometric analysis of FAC-sorted splenic T1 (upper)
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and mature B cells (lower) stained with D) Annexin V and propidium iodide (PI) after
12-15 hrs in culture with anti-Ig, or E) PI to determine the frequency of cycling cells after
24 hrs in culture either alone (media), with anti-Ig or anti-Ig plus CD40L (see materials
and methods). The numbers in the plot indicate the percentage of cells in the S and G2
phase. F) Somatic diversification of V regions of PCR-amplified VDJ genes from splenic
and appendix T1 B cells. The horizontal bar represents average number of nucleotide (nt)
changes/VH gene (excluding D and J regions); each dot represents one V H gene sequence.
Sequences obtained from two adult rabbits are shown. Data in B) to E) are representative
of 2-3 independent experiments. Data in A) are representative of two control and three
TACI-Ig treated rabbits.
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As shown in Fig 11A, most freshly isolated B cells in rabbit do not bind to
rBAFF. But, do transitional B cells bind BAFF? Because the CD24 hi T1 B cells were also
IgMlo, I tested if they represented the rBAFF+IgMlo subset that I identified in neonatal
rabbits (Fig 15A). I found that most BAFF-binding cells in the appendix and spleen were
CD24+ B cells, indicating that transitional B cells bind BAFF (Fig 17B). Further,
consistent with the localization of rBAFF-binding cells in the proliferation (Ki-67+)
region of B cell follicles in the appendix, I found T1 B cells in both appendix and spleen
were Ki-67+, indicating that they are cycling in vivo (Fig 17C). To functionally
characterize transitional B cells, I tested how they responded to anti-Ig stimulation in
vitro. Following anti-Ig treatment of FAC-sorted splenic T1 and mature B cells, T1 cells
did not progress into cell cycle, but instead underwent apoptosis (Fig 17D top left), while
the mature B cells readily entered cell cycle (Fig 17E middle). However, upon costimulation with CD40L, T1 cells did enter cell cycle, but at a reduced level compared to
mature B cells (Fig 17E, right). I also tested if the Ig genes in T1 B cells were somatically
diversified. Murine transitional B cells are constantly replenished from the BM and
consequently have unmutated Ig genes even in adults (Allman et al., 1993). Because new
B cells are not made in BM of adult rabbits (Jasper et al., 2003, Crane et al., 1996), I
predicted that T1 B cells in these rabbits would be diversified. I isolated T1 B cells from
spleen and appendix of adult rabbits and PCR-amplified and sequenced the Ig VDJ genes.
As expected, I found the IgH genes had undergone somatic diversification (Fig 17F),
suggesting that the B cells had been through a GC-like reaction and were not recent
emigrants from the BM.
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Figure 18: Flow cytometric analysis of T1 B cells in BM. A) BM cells from a young
rabbit (8 weeks of age) stained for CD21 and CD24, with histograms of IgM and CD62L
staining of cells in T1 (red) and M (blue) cell gates. The gray-filled histograms represent
staining with an isotype control mAb. B) BM cells from a young rabbit stained for IgM,
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MHC II and CD24, with CD24 histograms of cells in proB and preB & B cell gates. The
gray-filled histograms represent staining with an isotype control mAb. C) BM cells from
adult rabbits stained for CD24 and IgM. All plots are representative of staining obtained
from at least 3 rabbits.
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Transitional B cells in the BM
In young rabbits, where there is ongoing lymphopoiesis in the BM, I identified T1
B cells (CD24hiCD21loIgMloCD62Llo) (Fig 18A) and a CD24loCD21- population that I
thought might include proB and preB cells. To test if proB and preB cells are CD24 +, I
stained BM cells for MHC II and cytoplasmic IgM and found that proB cells and also
cells in the preB & B cell gate (presumably preB cells) were CD24 + (Fig 18B). In
addition to early B cell progenitors, the CD24loCD21- population might include other
lineages such as CD24+ stromal cells and common lymphoid progenitors (Israel et al.,
2005). In contrast to young rabbits, as expected, I found few, if any, CD24hi T1 B cells in
the BM of adult rabbits (Fig 18C). Nucleotide sequence analysis of the VDJ genes of
these T1 cells showed that the IgH genes were somatically diversified (Fig 17F),
confirming that they were not newly-made B cells. I suggest that the few diversified T1 B
cells in the adult BM may represent recirculating transitional B cells.
Tissue localization of transitional B cells
To determine the location of transitional B cells in spleen, I analyzed tissue
sections by immunohistology. Because anti-CD24 did not stain frozen tissue sections
effectively, I used anti-CD20, which binds all CD24+ B cells (T1 and T2 B cells) (Fig
16A lower). By using anti-CD23 to label the follicular zone, I found that CD20+
transitional B cells in spleen were located near the margins of the follicles and also in the
red pulp (Fig 19A). These data are similar to the localization of splenic transitional B
cells in mouse (Loder et al., 1999).
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Figure 19: Tissue localization of CD20+ transitional B cells. A) Immunohistological
staining of spleen (6-week old) section for CD20 (transitional B cells) and CD23
(follicular B cells); B) Flow cytometric and immunohistological analyses of tissues from
an IgH Tg rabbit stained for IgM and CD21 (top), and CD20 and IgM (bottom),
respectively. T = T cell areas. C) Staining for CD20 and IgM in appendix from normal 3
day and 6 day old rabbits (top). Arrows indicate CD20+ cells in the dome and villi. Lower
panel shows staining of a representative dome of the appendix from the 6 day old rabbit
(200X). D) Staining for CD20 and IgM in the villous region of appendix from a normal 4
week old rabbit. Magnification = 100X or 200X
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To localize transitional B cells in GALT during the early stages of B cell
development, I examined the appendix from an IgH transgenic (Tg) rabbit. These IgH Tg
rabbits are deficient in B cells early in ontogeny, but IgM+ B cells accumulate gradually
in the periphery during a span of several weeks to months. They appear first in the
appendix and SR and later in PP, MLN, blood and spleen (Jasper et al., 2007). The
delayed temporal appearance of B cells in these rabbits offered an opportunity to study
the early stages of peripheral B cell development. I examined one IgH Tg rabbit that
lacked IgM+ B cells in the periphery (PB and spleen), but had a few B cells in GALT (Fig
19B top) and found that the IgM+ B cells in the appendix were CD21lo (Fig 19B top
right), and CD20+ (Fig 19B bottom), suggestive of a transitional B cell phenotype. The B
cells were scattered, predominantly in the domes and villi of underdeveloped B cell
follicles located between large T cell areas (Fig 19B). IgM staining in the domes and villi
was not detectable (Fig 19B), presumably due to low expression of IgM on CD20 +
transitional B cells. Similar to IgH Tg rabbits, I identified transitional B cells in the dome
and villous regions of appendix from conventional neonatal rabbits (Fig 19C). At day 3
after birth, I found no identifiable IgM+ B cells in the follicles, but found a few CD20+
transitional B cells in the domes and villi. By day 6, these CD20 + cells accumulated in
number, along with IgM+ follicular B cells (Fig 19C). Similar to neonates, I found CD20+
cells located in the villous regions of the appendix of a 4 week old rabbit (Fig 19D). I
conclude that during development, transitional B cells migrate to the domes and villi of
the appendix prior to differentiating into follicular B cells. The unique and close
proximity of GALT transitional B cells to the intestinal lumen suggests to me that these B
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cells may interact with commensal bacteria or bacterial-derived products that promote B
cell activation and maturation in GALT.
CHARACTERIZATION OF MATURE B CELL SUBSETS
The presence of transitional B cells in the domes and villi of both IgH Tg, and
conventional neonatal rabbits, followed by the appearance of IgM+ follicular B cells
suggested to me that transitional B cells differentiate into follicular/mature B cells. I
phenotypically and functionally characterized the mature B cell subsets from different
lymphoid tissues.
Identification of follicular and MZ B cells in the spleen
Similar to identification of transitional B cell subsets in the previous section, I
identified follicular and MZ B cells based on their localization and expression of several
markers that are used to delineate mature B cell subsets in mice and humans. Because
CD23 is a marker for mature B cells and expressed in the follicular zone, but not in the
MZ of a B cell follicle (Wells et al., 1995), I used anti-CD23 mAb and identified two
populations of B cells in the spleen: CD23- and CD23+ (Fig 20A top) and found that the
CD23+ B cells were localized in the middle of a B cell follicle (Fig 20B top). Further, the
CD23- B cells had higher levels of surface IgM compared to CD23+ B cells (Fig 20A
top). These data indicate that anti-CD23 mAb can be used as a marker to identify
follicular zone B cells in rabbit. Further, the absence of CD23 staining around the
follicles and the higher expression of IgM on CD23- B cells suggests that MZ B cells are
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IgMhi CD23-, similar to the phenotype of rodent MZ B cells (Wells et al., 1995).
Although MZ B cells are defined primarily on the basis of their anatomical localization,
they are also identified based on the expression of a number of distinct markers. In mice,
they are broadly defined as CD23 -, CD1d+ (or CD1c+ in humans) and CD9+ (Pillai et al.,
2005). Because mAbs to rabbit CD1b isoform and CD9 are available, and these reagents
stain a subset of splenic B cells (Fig 20A middle), I tested whether CD1b and CD9 is
expressed on B cells in the MZ. I stained spleen sections with either anti-IgM or L Chain
Ab to identify B cell follicles (data not shown) and with anti-CD1b and anti-CD9 mAbs,
and found both CD1b and CD9 expressed in the margins of B cell follicles (Fig 20B
middle). CD9 expression was highest in the MZ, and was also expressed at lower levels
in some T cell areas (Fig 20B and data not shown). Taken together, these data indicate
that the MZ contains B cells that are CD23-IgMhiCD9hi and CD1b+.
In humans, because IgM+ IgD+CD27+ B cells reside in the MZ, CD27 serves as a
pan-marker for MZ B cells (Weill et al., 2009). Using an anti-CD27 mAb, I identified
CD27+ and CD27- B cells in the spleen and found that the CD27+ B cells expressed
higher levels of IgM compared to the CD27- B cells (Fig 20A bottom). By
immunohistology, I found CD27 expressed along the margins of B cell follicles (Fig 20B
bottom), indicating that CD27 also serves as a marker for rabbit MZ B cells. Further, I
found that the CD27+ gate included essentially all of CD9hi and CD1b+ MZ B cells, and
also contained CD21hi and CD38hi B cells, which are also characteristic of MZ B cells
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Figure 20: Identification of splenic MZ and follicular zone B cells A) Flow cytometric
staining of spleen cells for CD23, CD1b, CD9 and CD27 B cells (IgM+). B)
Immunofluorescent staining of spleen for CD23 and L-chain (LC) (top), CD1, CD9
(middle) and CD27 (bottom). C) Flow cytometric staining of splenic B cells for IgM and
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CD27, with CD38, CD9, CD21 and CD1b histograms of cells in IgM+CD27+ gate (blue)
and IgM+CD27- gate (red). Shaded histograms = isotype controls. Magnification = 100X

118

(Fig 20C). Taken together, these data indicate, that similar to humans, CD27 also serves
as a pan-marker to identify MZ B cells in rabbits.
Functional analysis of CD27+ and CD27- B cells
Human marginal zone (CD27+) B cells are large cells that secrete more Ig, and upon
stimulation, enter cell cycle rapidly compared to CD27- B cells (Maurer et al., 1992,
Agematsu et al., 1997). To examine if CD27+ B cells in rabbit exhibit similar properties, I
examined their size, and their response to stimulation with anti-Ig, CD40L and IL-4 in
vitro. Both by flow cytometry and cytospin analysis, I found that CD27 + B cells were
larger in size compared to CD27- B cells (Fig 21A and B). In vitro stimulated FAC-sorted
CD27+ B cells exhibited approximately a 2-fold increase in total Ig secreted relative to
stimulated CD27- B cells (Fig 21C). Further, following stimulation with anti-Ig, or costimulation with CD40L, I found a greater frequency of CD27 + B cells in cell cycle
compared to CD27- B cells (Fig 21D). Taken together, I conclude that CD27+ and CD27B cells represent functionally distinct mature B cell populations.
Mutational status of MZ B cells
One of the striking differences between rodent and human MZ B cells is that the
Ig genes of rodent MZ B cells are unmutated, while human MZ B cells possess a
diversified repertoire (Dammers et al., 2000, Dunn-Walters et al., 1995, Tierens et al.,
1999). To test if MZ B cells in rabbits are somatically diversified, I FAC-sorted a subset
of MZ B cells (CD9hi) identified in figure 20 and analyzed the Ig VH genes. Because I
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Figure 21: Functional analysis of splenic CD27+ and CD27- B cells A) Histograms
showing the forward light scatter (FSC) of CD27+ (blue) and CD27- (red) B cells. B) H
and E stained cytospins of FAC-sorted CD27+ and CD27- B cells. Magnification = 400X.
C) Bar graph showing the fold-increase in total Ig (as measured by ELISA) in the culture
supernatants of FAC-sorted CD27+ B cells, relative to CD27- B cells, which were both
stimulated in vitro for 8 days with murine CD40L and human IL-4 (see materials and
methods). The error bars = SEM calculated from fold changes obtained from three
independent experiments. D) Bar graph showing the frequency of cycling CD27+ and
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CD27- B cells (as assessed by flow cytometry) stimulated for 24 hours with anti-Ig alone
or co-stimulated with CD40L. The data are representative of two independent
experiments and the error bars = SEM.

121

122

Figure 22: Sequence analysis of Ig genes from splenic marginal zone B cells A) Flow
cytometric analysis of splenic CD23 - CD21hi IgMhi B cells for CD9 histogram (open).
Shaded histogram = isotype control. B) Somatic diversification of V regions of PCRamplified VDJ genes from FAC-sorted splenic CD23-CD21hiIgMhiCD9hi B cells. Eight
sequences compared to germline VH1 gene sequence are shown.
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performed this experiment before I identified the cross-reactive anti-CD27 mAb, I used
anti-CD23, anti-IgM and anti-CD9 mAbs to define MZ B cells. I FAC-sorted CD23IgMhiCD9hi B cells (Fig 22A), which represents approximately 20% of the B cells in the
spleen, and found that the Ig genes were somatically mutated (Fig 22B). From these data,
I conclude that CD9hi MZ B cells in rabbit possess a diversified repertoire.
Analysis of the splenic B cell compartment in adult GALTless rabbits
Vajdy et al. (1998) found approximately a 50% decline in the percentage of B
cells in rabbits in which all the organized GALT was surgically removed at birth. Are
particular subsets of mature B cells affected by the removal of GALT? Because frozen
tissues of the spleen from some of these GALTless rabbits were available, I analyzed
them by immunohistology and found a lack of staining for CD27 in the MZ (Fig 23A),
suggesting that MZ B cells were absent. I conclude that in the absence of GALT, the
splenic CD27+ MZ B cells do not develop. Using anti-CD23, I found the follicles in
GALTless rabbits were all essentially CD23+, while the B cell follicles in age-matched
control rabbits had clearly distinct CD23+ and CD23- areas (Fig 23B). Further, the
follicular zone, as defined by CD23+ staining appeared larger in size in GALTless rabbits
when compared to controls (Fig 23B). This increase in the size of the follicular zone
could be due to an expansion of the CD23+ B cells in the absence of CD27+ MZ B cells.
Further, the absence of these MZ B cells likely explains the reduction in the frequency of
B cells following removal of GALT at birth.
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Figure 23: Immunohistological analysis of spleen from GALTless and control
rabbits. Staining of spleen section from litter-mate control and GALTless rabbit for A)
L-chain (LC) and CD27 and B) LC and CD23. The two panels in B) represent different
areas of the tissue. The data are representative of staining obtained from 3 GALTless and
control rabbits.
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Figure 24: Analysis of CD27+ B cells in GALT and peripheral blood. A) Flow
cytometric staining of B cells from Apx, SR, PP, MLN, and PB with anti-IgM and CD27.
B) Immunohistological staining of SR, PP, and MLN sections for IgM and CD27
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MZ B cells in GALT and PB
MZ B cells in rodents are restricted to the spleen, while in humans, they are
circulating and present in several lymphoid tissues, including GALT (Steiniger et al.,
2005, Weill et al., 2009). Since MZ B cells do not develop in the absence of GALT, I
asked if these B cells could be derived from, and therefore present in GALT and other
lymphoid tissues. By flow cytometry, I found CD27 + B cells in Apx, SR, PP, MLN and
PB (Fig 24A). By immunohistology, I found these B cells scattered in the follicles of SR,
PP and MLN (Fig 24B). I conclude that similar to humans, CD27 + MZ B cells in rabbit
are present in GALT and likely circulating.
Expression of Notch2 and its ligand Jagged-1 in GALT
Studies using gene knock-out models in mice revealed that signaling through
notch2 and its ligands are required for MZ B cell development (Saito et al., 2003,
Hozumi et al., 2004). However, the site(s) where these notch2-ligand(s) interactions
occur is not clear (Pillai et al., 2005). Based on the absence of splenic MZ B cells in
GALTless rabbits, I hypothesized that notch-ligand interactions may occur in GALT.
Because introduction of commensals into GF appendices promote B cell development in
GALT, these tissues can be used to study the early stages of B cell development. I
examined if notch and its ligands are expressed in the reconstituted GF appendices, and
in support of my hypothesis, I found notch2 transcripts in the B cell follicles of GF
appendices into which B. subtilis and B.fragilis or B. fragilis alone were introduced (Fig
25A). I also found Jagged-1, one of the notch2 ligands expressed near the FAE (Fig 25B).
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Figure 25: Expression of notch2 and jagged1 transcripts in appendix. In situ
hybridization to detect notch2 (A), and Jagged1 (B) transcripts in the appendices from
GF-appendix rabbits into which commensals; B. subtilis & B. fragilis or B. fragilis alone
were introduced. The in situ hybridizations were performed by Dr. Dennis Lanning.
Magnification = 100X.
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This unique distribution of Jagged-1 near the FAE is reminiscent of the localization of
transitional B cells in the domes and villi (Fig 19C), and in close proximity to the
epithelial cells and commensal bacteria. As I discuss later, perhaps, transitional B cells
that engage with notch ligands in these sites are induced to differentiate in to MZ B cells.
Phenotypic and functional analysis of B cells in GALT
The GALT in rabbits is comprised of several tissues: appendix, sacculus rotundus,
Peyer’s patch and mesenteric lymph nodes. However, B cells from the appendix are
considered representative of GALT B cells and often, are the only GALT B cells studied.
Consequently, it is not known if phenotypically and functionally distinct B cell subsets
reside in the different compartments of GALT. To understand the nature of B cells in
these different tissues, I first examined their response to anti-Ig stimulation, with the
expectation that mature follicular B cells in these tissues will proliferate upon BCR
crosslinking, while immature or GC B cells will not proliferate, but undergo apoptosis.
Following stimulation with anti-Ig, I found that PP B cells proliferated in a dosedependent manner, whereas appendix and SR B cells did not (Fig 26A). As a positive
control for proliferation, I stimulated splenocytes with anti-Ig, and as expected found a
dose-dependent proliferation (Fig 26A). Further, 24 hours after BCR crosslinking, I
found that a large fraction of appendix B cells were caspase3+ (Fig 26B top), indicating
that those B cells were undergoing apoptosis. In contrast, only a small subset of splenic B
cells, (IgMlo) presumably transitional B cells were caspase3+ (Fig 26B bottom). The lack
of a proliferative response of appendix B cells to anti-Ig stimulation, and the induction of
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Figure 26: Functional analysis of B cells from various compartments of GALT. A)
Proliferation of B cells isolated from appendix, sacculus rotundus, Peyer’s patches and
spleen, cultured for 3 days in the presence of anti-Ig. Cells were pulsed with [3H]thymidine during the last 18 hrs in culture. The open triangles indicate increasing
concentrations of anti-Ig (5, 10, 20 µg/ml). B) Staining of B cells from appendix and
spleen for IgM and caspase 3, 0 and 24hrs after BCR crosslinking.
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apoptosis under those conditions, suggested to me that the appendix was composed of GC
B cells, which are known to respond poorly to BCR crosslinking (Holder et al., 1991). To
further characterize these GC-like cells, I analyzed B cells from various compartments of
GALT using markers that are characteristic of GC B cells in other species. Based on the
expression of surface IgM, I broadly classified GALT B cells as IgM hi or IgMlo. In the
appendix and SR, the IgMlo B cells predominated, whereas most B cells in the PP were
IgMhi (similar to B cells in the spleen) (Fig 27A). Because GC B cells downregulate
CD23 and express high levels of PNA (Butch and Nahm, 1992, Ingvarsson et al., 1999), I
stained cells for these markers and found that most B cells in the appendix were
CD23loPNAhi (Fig 27B and C), indicative of a GC B cell phenotype. The SR B cells also
appeared to be primarily GC B cells because they were mostly CD23 -PNAlo/int (Fig 27B
and C) and also because they did not proliferate in response to anti-Ig treatment (Fig
26A). In contrast to appendix and SR, the PP B cells appear to be primarily CD23 +PNAlo
mature B cells, similar to the B cells found in spleen (Fig 27B and C). Another
characteristic feature of GC B cells is that they are largely non-recirculating, and
therefore CD62L-, and express BCL6 (Reichert et al., 1983, Cattoretti et al., 1995).
Accordingly, I found essentially all appendix B cells were CD62L -, while mature B cells
in the spleen were largely CD62L+ (Fig 27D). Further, I found BCL6 expressed
predominantly in the dark zone-like areas (Fig 27E top) of the appendix where CD79a+
LC-/lo B lineage centroblasts like cells were located (Fig 27E bottom).
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Figure 27: Phenotypic analysis of B cells from various compartments of GALT.
Flow cytometric analysis of B cells from Apx, SR, PP, and spleen for IgM (A), CD23 and
IgM (B), PNA and IgM (C). D) Histogram (red) showing the expression of CD62L on
IgM+ (gated) B cells from the appendix and spleen. Blue histograms = isotype control. E)
Immunohistological staining of appendix section for BCL6 and LC (top) and CD79a and
LC (bottom). Magnification = 100X.
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Taken together, I conclude that most B cells in the appendix and SR are GC B
cells that are largely non-recirculating. Further, because PP B cells exhibited
characteristics similar to splenic B cells, I conclude that PPs are comprised of mature
follicular B cells. These findings reveal a previously unappreciated difference in the
composition of B cells residing in distinct anatomical locations of the gut; large intestine
(Appendix and SR) and small intestine (PP).
Identification of a small subset of mature B cells in the appendix
Although most B cells in the appendix were CD23 - GC B cells, I observed a small
subset of B cells (less than 5%) that were CD23+ (Fig 27B and 28A left). Further, I found
that approximately, 50% of these CD23+ cells were CD24+ (Fig 28A right), indicating
that cells within the CD23+ population include both CD24 -CD23+ mature B cells and
CD24+CD23+ transitional B cells. To determine if the CD24-CD23+ B cells were indeed
mature B cells, I FAC-sorted CD23+ B cells and found that upon stimulation with anti-Ig
and BAFF, they proliferated, while the CD23 - cells did not (Fig 28B), but instead
underwent apoptosis (Fig 28C). These results indicate that the small numbers of CD23+ B
cells in the appendix and presumably, in the SR are mature B cells.
Expression of activation markers on appendix and splenic B cells from adult rabbits
As reviewed in chapter 1, peripheral B cells in mice are constantly replenished by
the BM. When B cell production in the BM of mice was experimentally ablated, no
conventional B2 B cells were found. However, a small number of B cells (MZ and B1)
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Figure 28: Functional analysis of CD23+ and CD23-B cells from appendix. A) Flow
cytometric analysis of B cells for CD23, CD21 and CD24 B) Proliferation of FAC-sorted
CD21+CD23- and CD21+CD23+ B cells cultured for 3 days in the presence of anti-Ig
(10µg/ml) and sBAFF (3 µg/ml). Cells were pulsed with [ 3H]-thymidine during the last
18 hrs in culture. C) B cell subsets used in B) were assessed for their ability to undergo
apoptosis upon BCR crosslinking. Percent apoptotic cells at each time point were
calculated based on staining with annexin V and propidium iodide.
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expressing several activation markers were maintained, presumably by self-renewal (Hao
and Rajewsky, 2001). Because there is no influx of new B cells from the BM of adult
rabbits, I tested if rabbit B cells exhibit an activated phenotype. I analyzed appendix and
splenic IgM+ B cells for the expression of surface CD44, CD25, CD80/86, CD11b, and
CD43, markers that are characteristic of activated cells (Fig 29). I found that only a
fraction of appendix B cells were positive or stained weakly for these markers. The low
or weak expression of these activation markers in the appendix could be due to the
presence of only a small number of CD23+ mature B cells (Fig 29). In the spleen,
however, I was surprised to find that essentially all B cells were positive for these
markers, thereby exhibiting an activated phenotype. I was surprised because B cells in the
murine spleen are largely resting and do not express detectable levels of surface CD80,
CD86, CD69, and CD25 (Hsueh et al., 2002). As I discuss later, perhaps the activated
phenotype on rabbits B cells could be due to a chronic stimulation of the BCR by
tonic/survival signals that enable them to remain long-lived after the arrest of
lymphopoiesis in the BM.
Phenotypic analysis of rabbit B cell lines
The Knight lab generated three rabbit B cell lines: 55D1, PBL-1 and 79E that
were derived from the spleen, PB and MLN, respectively of c-myc transgenic rabbits
(Knight et al., 1988, Sethupathi et al., 1994). To facilitate the use of these cell lines in
investigating the biology of rabbit B cells, I characterized them based on the expression
of activation and CD markers (Fig 30A and B). I found 79E B cells
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(CD20+CD21+CD27+CD38+ and CD44-) were distinct from both 55D1 and PBL-1
(CD20-CD21-CD27lo/-CD38lo/- and CD44+) cells. The expression of CD27 on 79E B cells
suggests to me that they could represent MZ or memory-like B cells. As for CD20
expression on 79E cells, I will discuss later that CD20, although, a marker for transitional
B cells, can also be expressed at low levels on mature B cells. In conclusion, based on a
CD20+CD21+ CD27+ phenotype, I suggest that 79E B cells are mature B cells. It is
difficult to draw a conclusion about the nature of 55D1 and PBL-1 B cells based on the
phenotypes they present; CD21-/lo (Fig 30B), suggestive of a transitional B cell
phenotype, and surface CD24lo/-(data not shown), which is suggestive of a mature B cell
phenotype. Functionally characterizing 55D1 and PBL-1 B cells will provide further
insights into the nature of these B cell lines.
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Figure 29: Expression of activation markers on splenic and appendix B cells.
Histograms (red) showing the expression of CD44, CD25, CD80/86, CD11b, and CD43
on IgM+ (gated) B cells from the appendix and spleen. Blue histograms = isotype control.
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Figure 30: Phenotypic analysis of rabbit B cell lines; 55D1, PBL-1 and 79E. A)
Histograms (green) showing the expression of IgM, MHC II, CD80/86 and CD44. Red
histograms = isotype control. B) Histograms (green) showing the expression of CD20,
CD21, CD23, CD27 and CD38. Red histogram = isotype control.

CHAPTER FOUR
DISCUSSION
Mammals develop and maintain their B cell compartment through unique and
conserved mechanisms. In the process of investigating how B cells develop in rabbits, I
identified several immature and mature B cell subsets based on phenotypic and functional
characterization (summarized in table 4). Compared to other species, several unique
features of the B cell compartment were identified: (1) transitional B cells are present in
the peripheral tissues of adult rabbits long after the arrest of lymphopoiesis; (2)
transitional B cells in the periphery are proliferating and somatically diversified; (3) with
the exception of transitional and splenic MZ B cells, the BAFF-binding receptors of
essentially all B cells are occupied; (4) mature B cells in the periphery have an activated
phenotype, and (5) splenic CD27+ MZ B cells are absent in GALTless rabbits. While
these findings provide insights into how B cells develop, and are maintained; they also
raise several questions that need to be addressed to further understand rabbit B cell
biology. In the following sections, I will discuss these and other findings and the
implications they have for B cell development and homeostasis. I will also raise
important questions to be addressed and end with a model of B cell development in
rabbits.
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Table 4: Phenotypes and distribution of B cell subsets in adult rabbits

Subset

Phenotype

Tissue Distributiona

T1b

CD24hiCD21lo

T2

CD24hiCD21+

Apx, SR, PP, MLN,
Spl, PB
Spl

Mc

CD24lo/-CD21+

MZd

CD23-CD9hiCD1b+

GC

CD27+
PNAhiCD23-CD62LBCL6+

a

Apx, SR, PP, MLN,
Spl, PB, and BM
Spl

Apx, SR

Appendix (Apx); Sacculus rotundus (SR); Peyer’s patch (PP); Mesenteric lymph node

(MLN); Spleen (Spl); Peripheral blood (PB); Bone marrow (BM)
b

T1 B cells are also IgMloCD62lo when compared to T2 and Mature (M) B cells that both

express higher levels of IgM and CD62L
c

Mature follicular B cells are also CD23+

d

CD27+ MZ-like B cells are also found in Apdx, SR, PP, MLN, and PB
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Transitional B cells
Identification and characterization. As I mentioned previously, one major difficulty in
identifying B cell subpopulations in rabbits and other related species is the lack of
antibody reagents. I overcame this difficulty by using cross-reactive antibodies and
identified subsets of rabbit immature B cells using anti-CD24 mAb. The CD24hi
transitional B cells were classified into two subsets: T1 and T2 (CD21lo=T1; CD21+=T2).
Phenotypically, these transitional B cell subsets exhibited some differences and
similarities from their counterparts in other species. Unlike in mice, where T1 B cells are
IgD-IgMhi and T2 B cells are IgDhiIgMhi (Loder et al., 1999), transitional B cells in
rabbits differ only in the relative expression of IgM (T1=IgMlo; T2=IgM+). There is no
evidence for the expression of an IgD-like molecule on rabbit B cells (Knight and
Winstead, 1997). Both T1 and T2 B cells were CD23+, unlike in mouse where T1 B cells
are CD23- and T2 B cells are CD23+ (Loder et al., 1999). Based on the expression of
CD23, CD10, CD38 and CD20, rabbit transitional B cells appear similar to human
transitional B cell subsets. Like in rabbits, CD23 is expressed on both human T1 and T2like subsets and thus is not a useful marker to distinguish these B cell subsets (Suryani et
al., 2010). Further, as in humans, I found CD10 and CD38 could be used to characterize
rabbit transitional B cells. In humans, CD20 is expressed at high levels on transitional B
cells and also on all mature B cells (Sims et al., 2005), and thus serves as a pan B cell
marker. Interestingly, in rabbits, I found CD20 expressed only on transitional B cells. I
cannot however, rule out the possibility that CD20 is expressed at undetectably low levels
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on mature B cells. Nevertheless, this reagent (anti-CD20 mAb; clone B9E9) served as a
unique and additional marker for me to identify transitional B cells. In table 5, I
summarize the phenotypes of rabbit transitional B cells and compare them with human
and murine transitional B cells.
Functionally, transitional B cells in rabbits exhibit some similarities with their
counterparts in other species. In mice, BAFF is required for development of transitional
B cells as shown by the loss of mature B cells and the arrest of B cell maturation at the
T1 B cell stage in BAFF-deficient animals (Gross et al., 2001). By neutralizing BAFF in
neonatal rabbits, I demonstrated a similar loss of mature B cells and an arrest in B cell
development at the T1 B cell stage, confirming that transitional B cells in rabbit also
depend on BAFF for their development. Further, the absence of T2 and mature B cells in
the spleen following BAFF neutralization suggests that, similar to mice, T1 B cells in
rabbit are the earliest known precursor during peripheral B cell development and that
these cells likely give rise to T2 and mature B cells. I therefore characterized only T1 B
cells for subsequent functional analysis. Lastly, consistent with studies in mice and
humans (Allman et al., 1992, Sims et al., 2005), T1 B cells in rabbit did not enter cellcycle upon anti-Ig stimulation, while mature B cells readily entered cell-cycle under
similar conditions.
In addition to the similarities between rabbit and mouse transitional B cells
discussed above, T1 B cells in rabbit exhibit some unique characteristics. While murine
T1 B cells are largely non-cycling in vivo (Loder et al., 1999, Allman et al., 2001), I was
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Table 5: Phenotypes of transitional B cells in rabbit, human, and mouse

Rabbita

Humanb

Mousec

Marker
T1

CD24

T2

T1

T2

T1

T2

+++ +++ +++ +++ +++ +++

CD21

+

++

+

++

-/+

++

IgM

+

++

CD62L

+

++

+

++

-

+

CD23

+

+

+

+

-

+

CD10

+

++

++

++

ND

ND

CD38

+

++

+++

++

ND

ND

CD20

++

++

+++ +++

ND

ND

CD90

+++

++

ND

ND

ND

+++ +++ +++ +++

ND
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+++ = High ++ = Intermediate + = Low - = Negative
ND = Not determined (or not a marker)
a

As characterized on splenic B cells

b

(Carsetti et al., 2004,Sims et al., 2005, Marie-Cardine et al., 2008)

c

(Loder et al., 1999, Allman et al., 2001, Allman and Pillai, 2008)
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surprised to find that essentially all rabbit T1 B cells were proliferating in vivo. Further,
unlike in mice and humans (Mao et al., 2004, Sims et al., 2005), rabbit T1 B cells have
somatically diversified Ig genes. A diversified repertoire indicates that these cells have
undergone a GC-like reaction and are not recent emigrants from the BM. Further, the
presence of diversified T1 B cells in adult rabbits, long after the arrest of B
lymphopoiesis, suggests that these B cells are maintained in the periphery, possibly
because they are long-lived and/or self-renewing. Lastly, the rate at which transitional B
cells mature in rabbit appears to be faster than in mouse. HSAhi immature/transitional B
cells constitute most of the peripheral B cells in neonatal mice. They reach adult levels in
the spleen (5-10% of all B cells) only after 6-8 weeks of age (Allman et al., 1992, Allman
et al., 1993). In contrast, in rabbits, CD24hi transitional B cells are already present at the
levels seen in adults by approximately 7 days of age, suggesting that transitional B cells
rapidly mature in the lymphoid tissues, after they leave the BM. Because B
lymphopoiesis occurs only early in life, rabbits may have evolved this strategy to rapidly
differentiate their immature B cells and generate a functional B cell compartment before
the arrest of B lymphopoiesis.
Localization in GALT. Analysis of neonatal (3 and 6 day old) rabbits revealed that
CD20+ transitional B cells are localized in the domes and villous regions of GALT. These
findings suggest that BM-derived immature B cells first migrate to the domes and villous
regions of the appendix before differentiating into follicular B cells. Why do transitional
B cells enter domes and villi? What could be the significance of this unique pattern of
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localization? Because M cells in GALT are known to both translocate bacteria and
sample luminal antigens (Miller et al., 2007), I suggest that transitional B cells in the
domes that are in close proximity to the M cells interact directly with commensal bacteria
or with bacterial-derived products. Such interactions in GALT may promote further
differentiation and/or selection of B cells during peripheral B cell development. In
support of this idea are the following observations made in rabbits and mice. Both remote
colony and ligApdx rabbits, which have either limited and no microbiota, respectively, in
the appendix, have reduced numbers of peripheral B cells, when compared to
conventional rabbits (Lanning et al., 2000a). Similarly, the number of mature B cells in
germ-free mice is strongly reduced, while the numbers of T2 B cells remain normal
(Loder et al., 1999). Lastly, in a naturally occurring mutant rabbit, Rhee et al. (2005)
demonstrated that during ontogeny, commensal bacteria are required for the positive
selection of VHa allotype bearing B cells over VHn B cells. Taken together, these findings
suggest that commensal bacteria play a role in inducing the differentiation and/or
selection of B cells, presumably at the transitional B cell stage when they are present in
the domes and villi of GALT.
B cell development in GALT
Experimental models of B cell depletion followed by reconstitution have proved
useful in understanding the kinetics and stages of peripheral B cell development in other
species (Allman et al., 1993, Marie-Cardine et al., 2008, Palanichamy et al., 2009). The
Knight lab fortuitously developed such a model when they generated IgH transgenic
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rabbits, which were B cell deficient at birth. The subsequent appearance of IgM + B cells
in these animals, first in the appendix and SR, and later in PP, MLN, PB, and spleen
suggests that during development, B cells first migrate to the appendix and SR before
populating other tissues (Jasper et al., 2007). I identified that the IgM+ B cells in the
appendix of an IgH Tg rabbit were predominantly CD20+ transitional B cells and were
localized in the domes and villi, similar to the distribution of transitional B cells in
conventional neonatal rabbits. Taken together, the appearance of IgM+ B cells in the
appendix and SR of IgH Tg rabbits, and their localization in the domes and villi suggests
that during B cell development, (1) T1 B cells first migrate to the appendix and SR, and
(2) enter the domes and villous regions, before maturing into follicular B cells.
Stages of B cell maturation. How do T1 B cells mature in GALT? Following the
identification of T1 and T2 B cells in the murine spleen, Loder et al. (1999) proposed a
linear T1→T2→M pathway for B cell maturation. They found the intermediate T2 B
cells only in the spleen, while T1 B cells were found in blood, spleen, and BM. In rabbits,
consistent with the established role of GALT during early B cell development, T1 B cells
were also found in the appendix, SR, PP, and MLN, as well as in spleen and blood, while
T2 B cells were found only in spleen. Based on these findings, I suggest that B cell
maturation in the rabbit may also proceed in a murine-like T1→T2→M pathway. In
GALT, although I did not find a phenotypically distinct T2-like B cell population, the
presence of a small number of such intermediates cannot be ruled out. Alternatively, B
cell maturation in rabbit GALT may be distinct and not involve a T2 B cell-like stage, but
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may proceed directly in a T1→M pathway. In support of such a pathway, Roundy et al.
(2010) recently demonstrated that MZ B cells can in fact be directly generated from
immature/T1 B cells. Further, using mathematical models of the dynamics of peripheral
B cell subsets, Shahaf et al. (2004) provided evidence for the existence of alternate or
non-linear pathways for peripheral B cell maturation.
During the transitional stage of B cell development, a large number of selfreactive B cells that escape selection in the BM are purged from the mature B cell
repertoire (Carsetti et al., 1995). In humans, approximately 40% of the transitional B cells
are auto-reactive, and only about 50% of them develop into mature B cells (Wardemann
et al., 2003, Meffre et al., 2004, Wardemann and Nussenzweig, 2007). Where are selfreactive transitional B cells eliminated? Transitional B cells are first found in GALT, and
I suggest that it is in GALT that auto-reactive B cells are eliminated. An optimal level of
BAFF is required for B cell development as evidenced by the lack of B cell development
in the absence of BAFF (or low levels thereof), and the development of autoimmunity
due to the escape of autoreactive B cells in the presence of excess BAFF (Gross et al.,
2001, Mackay et al., 1999). BAFF expression in GALT is induced by commensal
bacteria, and I suggest that commensals regulate and maintain optimal levels of BAFF,
and thereby promote selection of transitional B cells. In support of this idea, rabbits with
GALT removed at birth (neonatal GALTless) developed an autoimmune-like phenotype,
whereas surgical removal of the spleen had no effect (Cooper et al., 1968). It appears that
in the absence of GALT, auto-reactive B cells accumulate in the periphery and secrete
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autoantibodies. This idea can be tested further by determining if the frequency of
transitional B cells in the spleen and other lymphoid tissues of neonatal GALTless rabbits
is increased.
Expansion of follicular B cells in GALT. Following the differentiation of transitional B
cells in GALT, large GC-like structures are formed due to the proliferative expansion of
follicular B cells. In the following paragraphs, I discuss some mechanisms by which B
cell expansion in GALT occurs.
To address whether B cells develop in a T cell independent manner, I attempted to
deplete T cells by surgical removal of the thymus and injection of anti-CD4 mAb at birth.
I found that neither of these treatments was effective in depleting T cells, presumably
because either T cells were already seeded in the periphery at birth and/or the level of
anti-CD4 mAb was insufficient. These treatments would likely be more effective in
depleting peripheral T cells if they are performed in utero. Since this option was not
available, I took an alternate approach and inhibited T cell activation by interfering with
B7:CD28 costimulation. The absence of a developmental phenotype in the appendix of
CTLA4-Ig treated rabbits, suggested to me that B cells in rabbit GALT develop in a T
cell independent manner. I found, however, that CD40:CD40L interactions are required
for B cell proliferation in GALT and although, the source of CD40L would usually be
activated T cells, several other cell-types, including DCs, macrophages, NK cells,
basophils, eosinophils, epithelial and endothelial cells, and B cells, (Schonbeck and
Libby, 2001) also express CD40L. I predict that these other cell types are the source of
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CD40L. In support of this idea, I demonstrated that CD40L is expressed throughout the
appendix tissue, not only in the T cell zone. To definitively demonstrate that T cells are
not required for peripheral B cell development, I recommend additional experiments in
which T cells are depleted by injection of anti-CD4 immunotoxin, e.g., anti-CD4
conjugated to ricin.
B cells in GALT could also be stimulated to proliferate through the engagement
of complement receptor CD21 (CR2) with its ligands; iC3b, C3d, and C3dg, breakdown
product of the complement pathway. CD21 on B cells is part of a co-receptor complex of
proteins: CD19 and TAPA-1 (CD81), which are known to provide co-stimulatory signals
(Matsumoto et al., 1993). The BCR and the co-receptor complex are crosslinked, when
CD21 binds to complement-coated antigen that has been captured by surface Ig; this
crosslinking results in the activation and proliferation of B cells (Carter et al., 1988,
Dempsey et al., 1996). By interfering with the interaction of CD21 and its ligand(s), and
also by depleting C3 with CVF, I showed that complement is required for B cell
development in GALT. The C3 staining I found in the appendix follicles could be due to
the deposition of complement-coated antigens on follicular B cells and/or on FDCs that
also express complement receptors CD21 and CD35 (CR1). In GCs, FDCs are described
as potent accessory cells for stimulating B cells. They trap complement-coated
(opsonized) Ag-Ab complexes [Immune complexes (IC)], and interact with B cells by
providing a FDC Ag- BCR interaction and a co-signal through B cell CD21-FDC CD21L
(opsonized antigen) (Tew et al., 2001). In GALT, I propose that B cells could be
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activated by FDCs that trap ICs made of bacterial-derived molecules and IgA. These ICs
could be derived from commensal bacteria that are coated with C3 and IgA.
Alternatively, the opsonized bacteria may be translocated by M cells and transported into
the follicles where B cells directly interact with bacteria and complement. The continuous
availability of such gut-derived microbial antigens in the follicles may support B cell
proliferation and expansion in GALT.
Little is known about the role of complement during B cell development in
GALT. Most studies about complement-mediated regulation of B cells are performed
within the context of an infection or humoral immune response (Chen et al., 2000). Using
GF appendices into which either no bacteria or select bacterial species were introduced, I
demonstrated that commensal bacteria regulate the expression/deposition of C3 in the
follicles. Further, because C3 was found in the presence of B. fragilis and B. anthracis,
which are both known to promote GALT development, but not in the presence of E. coli,
which does not induce GALT development, I suggest that one of the mechanisms by
which select commensals induce GALT development is through the activation of the
complement pathway. The bacteria could activate the classical pathway through IC
formed by natural IgM and bacterial-derived antigens and in turn, the IC could stimulate
B cells. Alternatively, bacteria could activate the mannose lectin-binding pathway which
is independent of Ig binding to the bacteria. Consistent with this latter pathway Casola et
al. (2004) showed that in mice that lack serum Ig, the complement cascade was activated
in the PP GCs. The authors suggested that activation occurred through the alternative or
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mannose-lectin binding pathway (Casola and Rajewsky, 2006). Further studies to
understand how commensals promote complement activation, and thereby B cell
developments in GALT need to be performed.
Mesenchymal stromal cells (SCs) could also stimulate GALT B cells to
proliferate in a contact-dependent manner. Griebel and Ferrari (1994) isolated SCs from
sheep ileal PP and generated a number of clones, and found that some of them supported
proliferation of ileal PP B cells, but not B cells from blood. Further, they found that the
proliferation was independent of antigen and T cells, but dependent on contact with SCs.
Neither the mechanism, nor the molecules involved in these B cell-SC interactions is
known. I predict that similar unique interactions may occur between B cells and SCs in
the rabbit GALT, and such interactions may contribute to the proliferative expansion of B
cells. This idea can be tested in vitro by co-cultures of appendix B cells and the sheep PPderived SC cell lines. If appendix B cells are stimulated by these SC lines, then I predict
that B cells would proliferate in these co-cultures. If sheep-derived SCs do not stimulate
B cells, then rabbit SCs could be isolated and cloned from the appendix and tested for
their ability to stimulate B cells.
Dramatic reduction in the size of proliferating B cell follicles in the appendix by
administration of TACI-Ig indicated that BAFF/APRIL is required during the early phase
of B cell development in GALT. In addition to promoting maturation of B cells, BAFF
may also aid in the recruitment of transitional B cells from the BM to GALT. Badr et al.
(2008) recently reported a novel role for human BAFF in B cell chemotaxis by showing
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that BAFF increased the chemotactic response of primary human B cells to a few
chemokines, including CXCL13. Interestingly abundant expression of BAFF and
CXCL13 (Hanson and Lanning, 2008) is found in the developing rabbit appendix,
suggesting that BAFF may similarly enhance the chemotactic response of incoming B
cells to CXCL13 produced by resident stromal cells/ FDCs. Results from the in vitro
analysis of appendix B cells, in which BAFF provides a survival rather than a
proliferative signal to B cells, suggests that BAFF plays a role in survival of the expanded
follicular B cells. Lastly, although TACI-Ig can bind and therefore neutralize both BAFF
and APRIL, the phenotype observed in TACI-Ig treated rabbits appears similar to BAFFdeficient mice, but not APRIL-deficient mice (in which B cell development is normal),
suggesting that the lack of BAFF rather than APRIL is likely responsible for inhibiting B
cell development in GALT.
I have not investigated the role of TLRs in GALT development, but these may
well have an important role in this development. The role of TLRs could be investigated
by disrupting MyD88 signaling in neonatal B cells through overexpression of Tollip, a
negative regulator of TLR signaling (Burns et al., 2000, Bulut et al., 2001, Zhang and
Ghosh, 2002). Mailly et al. (2006) developed a modified adenoviral vector, by inserting a
CD21 binding sequence, (derived from Epstein-Barr virus GP350/220 protein) into the
Ad fiber protein. Consequently, the tropism of the virus is modified such that it
recognizes and binds to CD21+ B cells. If this modified Ad vector also binds to rabbit
CD21+ B cells, then it could be used to overexpress Tollip in neonatal B cells. If TLR
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signaling is required for B cell development in GALT, then overexpressing Tollip in B
cells will block TLR signaling, and consequently inhibit B cell proliferation and
expansion. Additionally, by determining which TLRs are expressed on B cell subsets in
the appendix, we can predict which TLR ligands promote B cell proliferation in GALT.
Several anti-human TLR antibodies (TLR2, 3, 4, 6, 8, and 9) that cross-react with rabbit
(Dr. Lbachir BenMohamed; personal communication to Dr. Knight) are available for
these studies.
In summary, B cells in the appendix expand in a B7-CD28 independent, and
CD40-CD40L and CD21-CD21L dependent manner. BAFF, in addition to promoting
differentiation of transitional B cells, likely provides a survival signal for the
maintenance of B cells in the follicles.
Characteristics of mature B cells in GALT. Phenotypic and functional analysis of B cells
from various compartments of GALT revealed that the composition of B cells in the
appendix and SR were distinct. These tissues had only a few CD23+ mature B cells;
instead, most B cells were CD23- PNAhi GC B cells. In contrast, PP was similar to spleen
with mostly PNAloCD23+ mature B cells. These findings are reminiscent of ileal and
jejunal PP in sheep, where the former is a primary lymphoid organ, containing mostly
BAQ44- immature/GC B cells, while the latter is thought to function as a secondary
lymphoid organ, due to the presence of a predominant BAQ44+ mature B cell population
(Yasuda et al., 2006). Similarly, in rabbits, the appendix and SR may serve as primary
lymphoid organs, while the PP may function as a secondary lymphoid organ. This
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proposal is supported by the observations in IgH Tg rabbits, that IgM+ B cells are first
detected in the appendix and SR, prior to their detection in other GALT compartmentsPP and MLN. Further, unlike ileal PP in sheep, the appendix and SR in rabbit do not
involute with age, suggesting that these tissues may continue to function as primary
lymphoid organs even in adults. A few GC-derived CD23+ mature B cells from the
appendix and SR may continuously seed the periphery and maintain peripheral B cell
homeostasis, when there is no influx of B cells from the adult BM. Taken together, the
characterization of B cells from different compartments of GALT, revealed a previously
unappreciated aspect of appendix and SR B cells. During B cell development, the
transitional B cells that seed different compartments of GALT likely differentiate into
distinct effector B cell subsets- GC B cells in appendix and SR, and mature B cells in PP.
What could be the function of the GC B cells that occupy most of the follicles in
the appendix and SR? Because, they are CD62L-, I do not think that these cells enter the
periphery. Instead, as discussed above, I suggest that only the few CD23 + B cells in the
appendix and SR seed the periphery. Recently, Booth et al. (2009) found that PP B cells
in sheep spontaneously secrete high levels of IL10, an immunoregulatory cytokine, and
proposed that these IL10-secreting PP B cells are regulatory B cells (Bregs). They found
that PP B cells did not respond to CpG stimulation, despite expressing high levels of
TLR9, while B cells from other tissues readily responded to CpG stimulation. However,
in the presence of an IL10 neutralizing Ab, PP B cells responded, and secreted CpGinduced IFN and IL12 (Booth et al., 2009). In rabbits, B cells from the appendix did not
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proliferate in response to TLR7/8 agonists, while splenocytes and MLN cells exhibited a
dose-dependent proliferative response (Pi-Chen Yam & Katherine Knight, unpublished
observations). Given the similarities between sheep and rabbit GALT, I speculate that the
unresponsiveness of appendix B cells could be due to the presence of IL10 expressing
Breg-like cells in the appendix. Chronic proliferation and diversification of Ig genes in the
appendix may result in the generation of B cells with auto-reactive BCRs. I envision that
the Breg-like cells in these tissues could suppress the expansion of auto-reactive B cells
and thus help prevent autoimmunity. In conclusion, I suggest that the appendix and SR
play a role in maintaining peripheral B cell homeostasis, while PP and other GALT serve
as secondary lymphoid organs and confer protection against microbial pathogens.
Identification of MZ B cells
MZ B cells, defined by their distinct localization in the MZ constitute a
heterogeneous population of B cells with distinct surface markers. In both rodents and
humans, they are broadly identified by the lack of CD23, which stains only B cells
located in the follicular zone. In mice, MZ B cells are CD9 hi CD1d+ IgMhi CD38hi and
CD21hi (Oliver et al., 1997, Amano et al., 1998, Won and Kearney, 2002). In humans,
MZ B cells are CD1c+ IgMhi CD21+ and also CD27+ (Weller et al., 2004, Ettinger et al.,
2007, Sanz et al., 2008, Weill et al., 2009). Using these markers, I found that MZ B cells
in rabbit exhibit some characteristics of both human and murine MZ B cells. Anti-CD23
mAb did not stain B cells in the margins of splenic B cell follicles, indicating that MZ B
cells are CD23-. A few B cells in the MZ expressed the MHC class-I-like molecule,
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CD1b, similar to the expression of CD1 isoforms on human (CD1c) and murine (CD1d)
MZ B cells. Because rabbits express several CD1 isoforms that are homologous to human
CD1 isoforms (Hayes and Knight, 2001), it may be that rabbit CD1c is also expressed on
MZ B cells, but I did not have access to a CD1c antibody to test this. Further, I found B
cells in the MZ were CD9hi, a phenotype shared with murine MZ B cells (Won and
Kearney, 2002). Lastly, similar to humans, I found that CD27 was expressed on MZ B
cells, and the CD27+ B cells were IgMhi, CD21hi and CD38hi compared to CD27- B cells.
Human MZ B cells are distinct from their counterpart in the mouse in three
aspects. First, they are circulating, unlike murine MZ B cells, which are restricted to the
spleen. Second, they constitute 30-40% of the B cells, unlike in mouse where MZ B cells
represent only about 5-10% of the B cells. Lastly, human MZ B cells are somatically
diversified, while in rodents, they are undiversified (Weill et al., 2009). I found that in
rabbits MZ B cells appeared similar to human MZ B cells in all three aspects listed
above. In the spleen, CD27+ MZ B cells constituted 30-40% of the B cells and they were
also present in GALT and PB, suggesting that they are circulating. Splenic MZ B cells
(as identified by a CD23-IgMhiCD9hi phenotype) were also somatically diversified.
Morphologically, CD27+ B cells were larger in size than CD27 - B cells and in vitro, like
human MZ B cells, they secreted more Ig, and readily entered cell cycle upon stimulation
with anti-Ig, compared to CD27- B cells. Based on these findings, I suggest that the
peripheral B cell compartment in rabbits is similar to that in humans, where the CD27 +
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and CD27- B cell subsets can be considered as equivalents of the murine MZ and
conventional B2 B cells, respectively.
CD27 in humans is also a marker for memory B cells. Because CD27 + MZ B cells
are somatically diversified, some investigators define these cells as IgM memory B cells
(Tangye and Good, 2007). CD27 is also expressed on bonafide class-switched memory B
cells, which are known to reside in the MZ (Dunn-Walters et al., 1995, Klein et al.,
1998). Based on these criteria, CD27+ and CD27- B cells are broadly classified as
memory and naïve B cells, respectively. In a preliminary experiment to test if CD27 is a
marker for memory B cells in rabbits, I immunized an adult rabbit and FAC-sorted
CD27+ and CD27- B cells and stimulated them in vitro with CD40L and IL-4. By ELISA,
I found antigen-specific antibodies (IgG) in the culture supernatants of CD27 + B cells,
but not CD27- B cells. Further, I found that CD27 was expressed on some class-switched
(IgG and IgA) B cells in the spleen. These preliminary results suggest that CD27 may
identify memory B cells as well as MZ B cells in rabbit. Further experiments to confirm
these findings and test if CD27 is a marker for memory B cells need to be performed.
The absence of splenic CD27+ MZ B cells in rabbits that had GALT surgically
removed at birth indicates that the development of these mature B cell subsets is
dependent on GALT. Three possible mechanisms by which MZ B cells can develop are:
1) Transitional B cells in GALT are, or become committed to a MZ fate and migrate to
the spleen and differentiate in the MZ, 2) MZ B cells develop in GALT, and migrate to
the splenic MZ, or 3) MZ B cells develop in spleen, and GALT is required for their
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maintenance. Using notch2 and delta-like 1 (DL1) knockout mice, Saito et al. (2003) and
Hozumi et al. (2004) showed that signaling through notch2 is required for MZ B cell
development. It is proposed that T1 B cells come in contact with DL-1+ endothelial cells
lining the marginal sinus of the spleen and differentiate into MZ B cells (Pillai and
Cariappa, 2009). To test the possibility that transitional B cells in rabbit are committed to
a MZ fate and develop into MZ B cells in GALT, I examined whether notch2 and its
ligands are expressed in the appendix. The expression of the notch ligand, Jagged-1 near
the FAE in the domes suggests to me that T1 B cells that enter these sites during
ontogeny may come in contact with Jagged-1 or other notch2 ligand-expressing cells and
either become committed to a MZ fate or differentiate into MZ B cells. In this regard, it
will be important to determine if DL1 and other notch2 ligands are also expressed in
GALT. If DL1 is expressed in GALT, then its ability to promote differentiation of rabbit
transitional B cells into MZ B cells can be examined in vitro. Primary CD24hi T1 B cells
from GALT could be co-cultured with OP9-DL1 cells plus BAFF, and the cultures
examined for the development of CD27+ CD23- mature MZ-like B cells. This co-culture
approach was recently used by Roundy et al. (2010) to demonstrate that maturation of
transitional B cells can be induced in vitro, and that the commitment to a MZ or follicular
B cell fate can be dictated by DL1 and BAFF signals, respectively.
The origin and development of human MZ B cells (IgM+IgD+CD27+) is
controversial. Fully functional MZ B cells, as defined by the ability to mount an immune
response to T cell independent antigens, are not formed until a few years after birth
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(Timens et al., 1989). However, because IgM+IgD+CD27+ MZ B cells with mutated Ig
genes are already found in children below 2 years of age, it has been proposed that these
cells develop in GALT, in a manner seen in species such as sheep and rabbits (Weller et
al., 2004, Weller et al., 2008, Weill et al., 2009). The absence of splenic CD27+ humanlike MZ B cells in GALTless rabbits supports this possibility. Because of the similarities
between human and rabbit MZ B cells, I propose that rabbits can be used as a model to
understand human MZ B development and maintenance.
Maintenance of the peripheral B cell compartment in adult rabbits
The peripheral B cell compartment in many species is maintained by the
continuous production of new B cells in the BM. In rabbits, however, B lymphopoiesis in
the BM arrests by 4 months of age, and it is unclear how the peripheral B cell
compartment is maintained when there is no influx of new B cells. In the following
sections, I will discuss three unique features of the rabbit B cell compartment: 1)
presence of proliferating and somatically diversified T1 B cells in adults, 2) occupied
BBRs on B cells, and 3) activated mature B cells, and propose mechanisms by which the
B cell compartment is maintained in adult rabbits.
Presence of T1d B cells in adult rabbits. How are transitional B cells maintained in adult
rabbits and what is their significance? Because T1 B cells in adults are somatically
diversified, I designate them as T1d B cells to distinguish them from undiversified
immature B cells that are generated in the BM early in ontogeny. The Knight lab
previously demonstrated that GALT is required for somatic diversification of Ig genes
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(Vajdy et al., 1998) and that the Ig genes of essentially all peripheral B cells are
diversified by 6-8 weeks of age (Crane et al., 1996). I suggest that T1d B cells are also
likely generated by this time period in GALT and arise from the undiversified BM
immigrants. Following the arrest of B lymphopoiesis in adults, the proliferating T1d B
cells in GALT likely self-renew and thereby are maintained. Additionally, similar to selfrenewing murine B1 B cells, T1d B cells may possess a restricted BCR specificity to
certain self- and/or bacterial-antigens that promote their maintenance (Hayakawa et al.,
1984, Pennell et al., 1984, Pennell et al., 1989a, Pennell et al., 1989b, Hardy et al., 1989).
This idea of possessing a restricted repertoire can be tested by CDR3 spectratype analysis
of T1d B cells.
If the adult rabbit BM does not generate new B cells after 2 to 4 months of age,
then how is the peripheral B cell compartment maintained? I propose that it is maintained
in GALT by self-renewing T1d B cells. By administering TACI-Ig into neonatal rabbits, I
demonstrated that BAFF promotes the differentiation of T1 B cells into mature B cells.
Similarly, in adult rabbits, T1d B cells presumably continue to develop into mature B
cells in a BAFF-dependent manner, and thereby maintain B cell homeostasis. The few
CD23+ mature B cells that reside in the appendix and SR could likely be derived from
T1d B cells. I propose that the CD23+ B cells in appendix and SR continuously seed the
peripheral tissues and maintain peripheral B cell homeostasis. In vivo labeling of
lymphocytes in the appendix by injecting BrdU into the appendix artery, followed by
analysis of the kinetics of appearance, and frequency of BrdU +CD23+ B cells in the
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peripheral tissues could provide insight into the contribution of appendix-derived B cells
in maintaining B cell homeostasis.
Although I think T1d-derived (progeny) B cells in GALT and other tissues likely
maintain the peripheral B compartment, I cannot rule out the possibility that the BM may
periodically generate a small number of new T1 B cells. Nagaoka et al. (2000)
demonstrated that during an immune response to infectious agents, B lymphopoiesis in
the murine BM is perturbed, and there is a temporary accumulation of immature B cells
in the spleen. Similarly, it may be that B lymphopoiesis is temporarily reinitiated at low
levels in adult rabbits following an immune response, and the new B cells generated
during such a response could give rise to additional T1d B cells in GALT.
Occupied BBRs on peripheral B cells. Almost all human and murine B cells bind
recombinant BAFF and express BR3 as the dominant receptor (Schneider et al., 1999,
Thompson et al., 2001, Avery et al., 2003, He et al., 2004). However, in rabbits, I was
surprised to find that most B cells from GALT and PB did not bind rBAFF. I showed that
this lack of binding is not due to the absence of BR3, since almost all B cells expressed
BR3. Rather, I found that this lack of binding is due to prior engagement of BBRs with
endogenous BAFF. Carter et al. (2005) first demonstrated this phenomenon of BBR
occupancy on human B cells isolated from patients with SLE who have 2 to 10 fold
elevated levels of serum BAFF. They found that the level of labeled recombinant BAFF
bound to freshly isolated B cells was significantly reduced in SLE patients compared to
healthy controls due to occupied receptors. The saturated levels of occupied BBRs on
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rabbit B cells raise the possibility that BAFF is present at high levels in the serum. I
attempted to measure serum BAFF using the polyclonal anti-human BAFF reagent, and
was unable to detect BAFF by ELISA, presumably due to low sensitivity of the assay. In
the future, it will be important to measure serum BAFF using a recently described crossreactive anti-human BAFF mAb (Kikly et al., 2009).
The presence of occupied BBRs on rabbit B cells could also be due to the rapid
shedding of membrane BAFF on B cells. This possibility is supported by the weak
staining obtained for membrane BAFF using TACI-Ig as a reagent. Little is known about
the cleavage of membrane BAFF and how this process is initiated. Li et al. (2008)
showed that Fcγ receptor cross-linking triggers a rapid release of soluble BAFF from
myeloid cells. How is the cleavage of BAFF triggered on B cells? Most rabbit appendix
B cells express Fcµα receptor (FcµαR) and have IgA bound to their surface (Kari
Severson and Katherine Knight; unpublished observations). I hypothesize that binding of
IgA to FcµαR in the mucosal tissues trigger the release of BAFF from the surface of B
cells. To generate a tool for investigating the cleavage of BAFF on B cells, I developed a
BAFF-GFP fusion construct, whereby the GFP tag is on the extracellular portion of
BAFF. The role of IgA- FcµαR interactions in the cleavage of BAFF can be investigated
by the analysis of cleaved BAFF-GFP proteins in the culture supernatants of cells cotransfected with BAFF-GFP and FcµαR constructs, and cultured either in the presence or
absence of IgA. If binding of IgA to FcµαR triggers the release of BAFF, then one can
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expect to find more BAFF-GFP protein in the culture supernatant of cells with IgA
compared to those without IgA.
What could be the significance of occupied BBRs? I propose that the occupancy
of BBRs on B cells provides a tonic/survival signal, and consequently enables B cells to
remain long-lived. Because rabbit B cells themselves express BAFF, they could be
stimulated by BAFF in an autocrine fashion, and thereby remain long-lived. Although
constantly occupied BBRs may provide a positive signal, they can also negatively
interfere with any ongoing peripheral B cell selection, as seen in BAFF-transgenic mice
(Mackay et al., 1999). These observations suggest that the BAFF signaling in rabbit B
cells with occupied BBRs must be carefully regulated to maintain B cell homeostasis.
How could BAFF signaling be regulated? Recently, a novel isoform of BAFF, known as
delta-BAFF, was shown to dampen the co-stimulatory functions of BAFF in vitro, and
also interfere with the binding of sBAFF to BBRs (Gavin et al., 2003). In vivo, deltaBAFF transgenic mice had reduced numbers of B cells, in contrast to BAFF transgenic
mice that had an increased number of B cells (Gavin et al., 2005). These findings indicate
that the presence of delta-BAFF can modulate the response of B cells to BAFF. Thus,
investigating if rabbit B cells also express a delta-BAFF-like isoform could provide
insights into how BAFF signaling is regulated in B cells with occupied BBRs.
Activated phenotype of mature B cells. The expression of activation markers on
essentially all splenic and mature B cells in the appendix suggests that B cells in adults
are activated. This is in contrast to the mouse, where essentially all the conventional B2
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B cells in the spleen are in a resting state and do not express detectable levels of
activation markers such as, CD69, CD25, CD80, and CD86 (Hsueh et al., 2002).
However, in mice, in which B cell development in the BM was blocked, the few B cells
(mostly MZ and B1 B cells) that were maintained in the periphery had an activated
phenotype (Hao and Rajewsky, 2001). An activated state of these B cell subsets could
presumably be due to chronic engagement of the BCR with tonic/survival signals and/or
constant recognition of self-antigens that may promote maintenance. Because rabbit B
cells also appear to be in an activated state, they may utilize some of the strategies
adopted by MZ and B1 B cells for their maintenance. These cells could be self-renewing
and/or long-lived. CD5, which is expressed on almost all rabbit B cells (Raman and
Knight, 1992), has been shown to interact with surface Ig on rabbit B cells in a
superantigen-like manner, and these interactions have been proposed to contribute
towards the maintenance/longevity of B cells in adults (Pospisil et al., 1996). The chronic
engagement of CD5 and its ligand(s) could be one reason why B cells are in an activated
state. To investigate if rabbits B cells are long-lived and/or self-renewing, a rabbitizedmouse model can be developed by injecting T1d or T1 B cells into NOD/SCID mice. If
these transitional B cells differentiate into mature B cells in the NOD/SCID mice, then
the life-span and turn-over kinetics of rabbit B cells can be investigated in this model.
Model of peripheral B cell development
Based on my findings and previous observations made in the Knight lab, I
propose a model (Fig 31A) of peripheral B cell development: CD24 hi immature B cells
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exit the BM early in ontogeny as transitional (T1) B cells (IgMloCD21loCD62lo). These
T1 B cells traffic to GALT (appendix) and enter the domes and villi (Fig31A inset). Here,
they interact directly with either commensal bacteria or bacterial-derived products, such
as superantigens (Severson et al., 2010) and become activated. Following activation, T1
B cells, proliferate, somatically diversify the Ig genes and differentiate into both follicular
and T1d B cells. While the follicular B cells expand in a B7-CD28 independent, CD40CD40L, and CR2-CR2L dependent manner in GC-like structures, the diversified T1d B
cells leave the appendix and seed other peripheral tissues where they further develop to
give rise to mature B cells. Alternatively, some of the BM-derived T1 B cells may also
directly traffic to other sites, such as the spleen and develop into mature B cells. In the
absence of newly-formed B cells from the BM, the T1d B cells that are presumably
maintained in adult rabbits through self-renewal continually develop into mature B cells
and thus maintain peripheral B cell homeostasis. Additionally, B cell homeostasis is
maintained by long-lived mature B cells that have occupied BAFF-receptors (Fig 31B).
If my model of peripheral B cell development and maintenance in adult rabbits is
correct, then I can make several predictions. First, if GALT maintains the peripheral B
cell compartment by serving as a reservoir for T1d B cells, then following the surgical
excision of organized GALT (GALTless) in adults, the frequency of peripheral B cells
will decline over time. Further, if transitional B cells are not replenished by the BM and
peripheral B cell homeostasis is maintained by T1d cells, then selective depletion of T1d
B cells in adults would be expected to result in B cell lymphopenia. If GALT continues
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Figure 31: Model of peripheral B cell development and maintenance A)
Development of T1d B cells. T1 B cells leave the BM and enter GALT (appendix)
through the HEVs and traffic to the domes and villi, where they are stimulated by BAFF
and commensal bacteria or bacterial-derived products. The activated T1 B cells
somatically diversify the Ig genes to become T1d B cells, which then directly
differentiate into follicular B cells that undergo a proliferative expansion to form
organized follicles in a CR2-CR2L and CD40-CD40L dependent manner. After
undergoing the GALT GC-like reaction, mature and T1d B cells enter the circulation.
Some of the GALT-derived T1d B cells traffic to the spleen and differentiate into T2 and
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mature B cell subsets. Alternatively, some T1 B cells from the BM may directly traffic to
the spleen and develop into mature B cells (not shown). B) Maintenance of peripheral B
cells. In adult rabbits, in the absence of ongoing lymphopoiesis, the B cell compartment
is maintained by proliferating T1d B cells which self-renew and continually differentiate
into mature B cells. Additionally, the BAFF receptor(s) on mature B cells in the
periphery are bound by endogenous BAFF and this chronic engagement of BAFF
receptors may provide a tonic/survival signal for the B cells to remain long-lived.
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to function as a primary lymphoid organ in adult rabbits, then following depletion of
mature B cells (but not T1d B cells) by a BAFF neutralizing agent [such as LY2127399,
a crossreactive mAb (Kikly et al., 2009)] the rate of peripheral B cell reconstitution (after
withdrawal of the BAFF neutralizing agent) will be much slower in GALTless rabbits
compared to control B cell-depleted rabbits with intact-GALT. Lastly, another prediction
is that both the BAFF-bound mature B cells and proliferating transitional B cells are
long-lived and self-renewing, respectively. Experiments to test these ideas will elucidate
some of the mechanism(s) by which rabbits and other species, that do not exhibit
continuous B lymphopoiesis, develop and maintain their B cell compartment.
Concluding remarks
Different species have evolved different strategies to develop and maintain their B
cell compartment. For my dissertation work, I focused on understanding how B cells in
rabbits develop, and are maintained in adults. I identified and characterized transitional
B cells in rabbits and by extension, in mammals that use GALT to develop their B cell
repertoire. Remarkably, transitional B cells are maintained in the periphery of adult
rabbits, when there is no evidence for ongoing lymphopoiesis in the BM. The finding(s)
that these cells have a diversified repertoire and are undergoing proliferation confirms
that these cells are not newly-made, and instead, leads to the idea that the T1d B cells are
maintained by self-renewal and are responsible for maintaining the B cell compartment in
the absence of detectable B lymphopoiesis. Further, the finding that B cells have
occupied BBRs, suggests that rabbit B cells may be long-lived. These results provide
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insights into how B cells develop, and are maintained not only in rabbits, but also in other
species that exhibit limited B lymphopoiesis.
In 1979, Stewart Sell stated that most of our knowledge of the mammalian
immune system is derived from studies in the mouse (Sell, 1979). This statement holds
true even today, after almost three decades. In this article, the author discussed the
advantages and disadvantages of using mice as a model to understand B cell biology.
Although B cell development in mice appears similar to humans in some aspects, there
are also significant differences, especially with regard to the composition of B cell
subsets in the peripheral tissues. The presence of CD27+ and CD27- B cells in rabbits
suggests that rabbits have human-like memory and naïve B cell compartments. Further,
many of the markers expressed on rabbit transitional B cells are also found on human
transitional B cells, suggesting that rabbits can be used as a model to study human
peripheral B cell development. Finally, I suggest that similar to rabbits, subsets of human
transitional B cells may be found in the intestine and GALT and contribute to the
maintenance of peripheral B cells as B lymphopoiesis in the BM decreases in the elderly.
In conclusion, as stated in chapter one, I would like to reiterate that the immune
system of several species need to be investigated to obtain a holistic understanding of the
immune system. It is my hope that the identification of several crossreactive antibody
reagents and the functional characterization of rabbit B cells as described in this
dissertation will serve as a basis for further studies in the rabbit and help establish rabbits
as an alternate model to understand the human immune system.
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